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PREFACE 
The work described in this thesis involves a study of the synthesis 
of the vitamin niacin in the bacterium Escherichia coli. When not 
supplied to the bacterial cells, the vitamin and its precursors must be 
synthesized from small molecules in tqe cell. The direct precursor from 
these small molecules is quinolinic acid (QA). The enzymes responsible 
for the formation of QA in E. coli are not well characterized. The 
objective of this study was to purify one of the proteins that take part 
in QA biosynthesis and to further characterize the quinolinate 
synthetase system in !· coli. 
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CHAPTER I 
INTRODUCTION 
Extensive study of the pathways of vitamin,biosynthesis has been 
carried on, since the discovery of each vitamin's nutritional signif-
ic.!mce, Often the discovery and elucidation of the biochemical function 
of.the cofactor form of the vitamin occurred before its role.in the diet 
was known. This was the case with .niacin, and its corresponding cofac-
+ tor form NAD • Research was focused upon the bfosynthesis of niacin and· 
+ later upon its relationship to NAD. Out.of the results of such work 
emerged the knowledge of. two general routes for niacin.formation: one 
from tryptophan and the other from three and four-c~rbon mol~cules in 
the cell. Further work showed that the latter type-of pathway utilizes 
different precursors in diff~rent organisms. It was.also discovered 
that quinolinic acid is a common intermediate in these.pathways and 
+ therefore a common precursor of NAD, Much work was also done on the. 
+ many interconversions of NAD and other nicotinyl compounds in the cell, 
the sum of which was found to be a cyclic mechanism operating in most 
+ organi$ms •.. The key role of NAD in cellular metabolism in all organ-
isms hl;ls stimulated investigation of its biosynthesis and the mechanism 
of it;:s functioning as a cofactor of biological oxidation-reduction 
reactions. 
+ Escherichia ~ can synthesize NAD by two methods: . de ~ 
synthesis of quinolinic acid or utilization of exogenous niacin, which 
1 
2 
is called the "salvage. pathway''· This study concerns itself with the 
+ de ~ synthesis of NAD ; and, more specifically, with the synthesis of 
QA. QA synthesis occurs by the action of at least·two proteins~ termed, 
11A11 and 11B11 • Genetic characterization has.identified mutants which lack· 
the act~ve A protein, nad A mutants, and mutants which lack t~e ac~ive B 
protein, nad ,! mutl;lnts. An assay developed for measuring synthesis of 
QA in.vitro has been used to show that extracts of a nad A mutant, con-
taining the active B protein, and extracts of a nad ,!mutant, containing 
the active A protein, will synthesize QA when mix~d with the necessary 
substrates. This system can be utilized for studying QA synthesis in 
E. coli. 
This study was directed.toward reachi~g a better understanding of. 
the properties of tQe quinolinate synthetase system in E. coli. Pri-
marily, this goal was approached by purifying the B protein to as great 
an extent as possible, in order to permit more.detailed study of the 
intermediates, if .any, the reactions, and the kinetics and mechanisms of 
QA biosynthesis. 
CHAPTER II 
LITERATURE REVIEW 
Nicotinic acid received its name in Germany in 1867 when Huber (1) 
oxidized nicotine to nicotinic acid. Later he showed its structure to 
be pyridine-3-carboxylic acid (2). While searching for the anti beri-
beri factor in 1911, Funk (3, 4) isolated nicotinic acid coincidentally 
from yeast and rice bran. Suzuki ~al. (5) also isolated the compound 
from rice bran without knowing its nutritional significance. 
Since the early 1700's, pellagra· has been recognized as a human 
disease, many times occurring in epidemic proportions. Not until 1925, 
however, was it established that pellagra is a vitamin-deficiency 
disease that could.be cured by yeast, which contained a 11PP 11 or pellagra-
preventative factor (6). Better results in pellagra.treatment were 
shown by Elvehjem ~·.al. (7) in 1937 when they isolated nicotinic acid 
from liver extracts and used it to cure blacktongue, the corresponding 
conditi,on in dogs. Then later in 1937 and in 1938, several inve9tiga-
tors announced conclusively that nicotinic acid would cure pellagra in 
humans (8, 9, 10). Furthermore, tryptophan was found to substitute for 
nicotinic acid in the mammalian diet (11), suggesting a precursor rela-
tionship between tryptophan and nicotinic acid. Subsequently, nicotinic 
acid (niacin) and nicotinamide (niacinamide) have been shown to be 
present .in small amounts in, and essential to the function of all living 
systems. 
3 
4 
Before the discovery of nicotinic acid as a vitamin, however, its 
biochemical function was described, beginning with the work of Harden 
and Y9ung in 1904 (12). They observed that a dialyzable cofactor was 
required to stimulate alcohol production from glucose in yeast extracts. 
This cofactor ("cozymase" or "coenzyme I 1,1) was shown. to contain 
nicotinamide by von Euler, Albus, and Schlenk (13). This conclusiQn was 
confirmed later by Warburg and Christian (14). However, Warburg and 
Christian (15, 16) also found another dialyzable cofactor that could not 
substitute for the one observed by Harden and Young. They quickly 
determined that this cofactor ("co-ferment" or coenzyme II") also con-
tains nicotinamide (16). 
These.cofactors are now known as nicotinamide adenine dinucleotide 
+ + + (NAD , DPN ) and nicotinamide adenine dinucleotide phosphate (NADP , 
TPN+), respectively. Their structures were elucidated within a few 
years of their discovery by VQn Euler~ al. (17, 18) and Schlenk (19, 
20). Although postulated by von·Euler in 1934, the hydrogen-transfer 
funct,ion of NAD+ and NADP+ was not demonstrated until the work 0f 
Warburg and his associates (14, 16, 21). Later, the reversible transfer 
of hydrogen was sh0wn to take place at the 4-position of the pyridine 
+ + ring of NAD and NADP by several investigators (22, 23, 24). The 
reduced forms of these cof actqrs were designated NADH and NADPH. The 
+ + coe~zyme function o~ NAD and.NADP with oxidorequctase enzymes has 
since been observed in.over 290 different.biological reactions (25). 
+ The general metab0lic role of NAD is as a cofactor for energy-yielding 
+ oxidations in the cell, whereas NADP serves as the source of bio~ 
synthetic reducing power in cellular metabolism. Figure 1 shows the 
+ structures of NAD and related compounds. 
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Figure 1. Structures of Nicotinic Acid, Nicotinamide, 
Quinolinic Acid, and Pyridine Nucleotides 
+ Additional Biological Roles of NAD 
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+ In addition to its major role, NAD has been found to possess other 
functions in the cell. In 1967, after partial purification of a poly-
nucleotide-joining enzyme ("DNA-joining enzyme" or DNA ligase) from 
Escherichia coli (E. coli) (26, 27), two groups of investigators (27, 
+ 28) promptly found NAD to be a specifically requited cofactor for the 
phosphodiester bond formation" 1-In the reaction, NAD is not reduced but 
is cleaved to S'-AMP and NMN, DNA ligase has various functions in 
genetic recombination, repair, and DNA synthesis. The enzyme has been 
purified since its discovery from uninfected (29) and phage-infected 
(30) !· .££J4. cells, mammalian cells (31), and higher plants (32). Only 
+ the!· coli enzyme requires NAD; others utilize ATF (29, 30). 
Also, in 1964, Collier and Pappenheimer (33) reported the require-
ment of NAD+ as an essential cofactor for the diphtheria toxin-depend-
ent inhibition of the i.ncorporation of amino acids into polypeptides in 
cell-free systems from mammalian cells. Later, Collier (34) showed the 
·+ site of action of the toxin and NAD to be the aminoacyl-transferase II 
(elongation factor 2) enzyme, It is now known that dip.htheria toxin 
+ catalyzes the transfer of the ADP-Ribose portion of NAD to the trans-
ferase II, thereby inactivating the transferase and releasing nicotin-
amide (35, 36, 37), Recently, this reversible ADPR-transferase activ-ity 
of the toxin has been further characterized as to structure and action 
(38, 39). 
The multiple functions and wide distribution of NAD+, therefore, 
point to the key role this compound plays in the metabolism of the cell. 
+ De lieY.2. Biosynthesis of NAD 
Since Krehl, ~al. (11) conducted nutritional studies on the 
tryptophan-niacin relationship in the rat, it has been found that 
trytophan can replace niacin as a growth requirement in many different 
organisms. The tryptophan-niacin relationship does not exist, however, 
in many species of microorganisms and several species of plants that 
have been tested. Thus, another pathway for niacin and therefore :i:;{AD+ 
biosynthesis must operate in these organisms. Table I summarizes the 
species known to exist with or without the tryptophan pathway. 
+ Precursors of NAD in E. coli 
+ Investigation of the precursors of NAD in §_. £Q,!i began in 1960 
when Ortega and Brown (60) demonstrated efficient incorporation of 
14 14 C-succinic acid and C-glycerol into nicotinic acid in a cons~stent 
labeling pattern. Maximum synthesis of NA in the resting cell suspen-
7 
sion occurred when ri~ose and adenine were also present. The conclusion 
from this work was that the precursors of NA in E. coli are a 4~carbon 
dicarboxylic acid and glycerol or a metabolically related compound. 
After the demonstration that quinolinic acid (pyridine-2, 3-dicarboxylic 
+ acid) is a precursor of NAD (61), Ogasawara et al. (62) showed incorpo-
14 
ration of C-aspartic acid into carbons 2, 3, 7, and 8 of QA in cell-
free extracts of §_. coli. This study utilized a mutant lacking the 
+ ability to convert QA to the next intermediate in NAD formation. 
Then Chandler, et al. (63), using crude extracts of these QA-
accumulating mutants (QRTase mutants), carried out incorporation of 
14c . 
-aspartic 
14 C-aspartic 
. 14 14 
acid, C-glycerol, and C-glucose into QA. The DL-1-
14 14 14 
acid formed 7- C-QA, 1,3- C-glycerol formed 4,6- C-QA, 
TABLE I 
THE TRYPTOPHAN-NIACIN RELATIONSHIP 
Organism(s) 
Tryptophan is a Precursor of Niacin 
Mammals and fowl 
Neurospora crassa 
Rhodotorula glutinus 
Fusarium oxysporum 
Claviceps purpurea 
Saccharomyces cerevisae (aerobic) 
Streptomyces antibioticus 
Cyanidium caldarium 
Karlingea rosea 
Xanthomonas begoniae 
Xanthomonas manihotis 
Xanthomonas pruni 
Tryptophan is Not a Precursor of Niacin 
Escherichia coli 
Baci.llus subtilus 
Lactobacillus arabinosus 
Leuconost6c mesenteroides 
Streptococcus f aecalis 
Proteus vulgaris 
Torula cremoris 
Streptomyces venezulae 
Anacystis nidulans 
Chlorella pyrenoidosa 
Saprolegnia f erax 
Xanthomonas trifolii 
Pseudomonas aeruginosa 
Pseudomonas iodinium 
Mycobacterium phlei 
Saccharomyces cerevisae (anaerobic) 
Mycobacterium tuberculosis 
Clostridium butylicum 
Serratia marcescens 
~mays 
Nicotiana rustica 
Ricinus communis 
Referenc~ 
(40, 41) 
(42' 43) 
(44) 
(45) 
(46) 
(47) 
(48) 
(48) 
(48) 
(49) 
(49) 
(SO) 
(51) 
(51) 
(52) 
(52) 
(52) 
(52) 
(52) 
(48) 
(48) 
(48) 
(48) 
(49) 
(49) 
(49) 
(49) 
(47) 
(53, 54) 
(55, 56) 
(57.) 
(58) 
(58) 
(59) 
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and·l4c-glucose (1, 2, or 6-labeled) labeled the 4 and 6 positions most 
heavily, with some randomization. These results led to the suggestion 
+ that QA, as a precursor of NAD in !• coli, is synthesized .!n, vitro by 
the direct condensation of a triose-phosphate and L-aspartate. Later 
14 14 
work (64) in the same system showed that C-succinate, C-glycerol, 
9 
14 14 14 C-aspartate, C-fructose-1,6-diphosphate, and C-2,3-diphosphoglycer-
14 14 14 
ate are incorporated into QA, whereas C-glycerate, C-acetate, C-
3 3 formate, H-glycerol, and H-aspartate are not. These data confirmed 
the role of the suggested compounds as precursors of QA. Most recently, 
Suzuki =E._al. (65) determined the triose phosphate to be dihydroxy-
acetone-phosphate (DHAP) and not glyceraldehyde-3-phosphate, utilizing 
an effective inhibitor of triose-phosphate isomerase, an enzyme present 
in the protein fractions. 
Thus, while the precursors for de ~ biosynthesis of NAD+ in!· 
.£21!_ have been elucidated as L-aspartate and dihydroxyacetone-phosphate, 
the intel'1Il.ediates and enzymes in the pathway to QA,at least, are not yet 
known. Figure 2 depicts the isotope incorporation patterns known. 
+ Precursors of NAD in Other Microorganisms 
Two other microorganisms have been the subject of considerable 
+ investigation to determine the precursors of NAD • One of these, 
Mycobacterium tuberculosis (M. tuberculosis), studied because of its 
human pathogenicity, was shown.to form niacin from aspartic acid by 
Mothes, et al. (53). 
--
14 Using DL-4- C-aspartic acid, they observed that 
the carboxyl group of nicotinic acid originates from carbon 4 of the 
aspartic acid. Results with unlabeled precursors (54) agreed with the 
* 
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Figure 2. Labeling Patterns from Radioactive 
Precursors of Nicotinic Acid or 
Quinolinic Acid in Bacteria and 
Plants 
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11 
aspartate incorporation and suggested the involvement of alanine, but 
14 failed to show stimulation by glycerol or incorporation of 2- C-glycerol 
in niacin synthesis in resting cells. 
Further substantiation of the role of aspartate as a precursor of 
NA in M, tuberculosis by Gross, et al. (66) employed DL-l,4-14c, 15N-
aspartic acid and calculation of isotope ratios. Carbons 2, 3, and 4 
and the ring of nitrogen of NA are derived directly from aspartic acid. 
Thus, in the utilization of aspartate, carbon 1 is lost but all other 
carbons and the nitrogen are incorporated (67). Albertson and Moat (68) 
conducted experiments with 3-14c and 4-14c aspartic acid which were in 
agreement with previous results, but in contrast to one previous study 
14 (54), they demonstrated incorporation of carbon 2 of 2- C-glycerol into 
the pyridine ringo The role of glycerol (or a metabolite of glycerol) 
14 
was more clearly indicated by the incorporation of 1,3- C-glycerol and 
14 3- C-glyceric acid into carbons 4, 5, and 6 of the pyridine ring (69). 
Carbon 6 was exclusively derived from carbon 3 of the glyceric acid, 
indicating a symmetrical intermediate does not occur. In the same 
14 . 14 
study, C-formate and C-acetate were shown not to be precursors of 
NA. 
Excretion and precursor studies with isotopes in M, tuberculosis 
and M. bovis (the corresponding bovine pathogen) have strongly indi-
cated that QA is an intermediate in niacin synthesis (69, 70, 71). 
14 . 14 14 Experiments have utilized C-aspartic acid, C-glycerol, and C-
glyceric acid to produce 14c-QA, which was isolated and identified from 
14 14 . 
media or extracts. C-QA was also found to be converted to C-NA in 
cell extracts. 
12 
+ The pathway for NAD biosynthesis in _tl. tuberculosis, then, to the 
extent that it has been investigated, appears to have identical precur-
sors and intermediates as the .de B.QY.Q_ system in ~· coli. 
Investigation has been carried out in Clostridium butylicum (f. 
butylicum), a strict anaerobe. Isquith and Moat (55) found both uni-
formly labeled aspartate and glycerol to be incorporated into nicotinic 
acid in crude extracts, but upon fractionation of the extract, only 
aspartate, acetyl CoA, and formate stimulated NA production. Incorpora-
14 14 . 14 tion of C-aspartate, C-acetate, and C-formate into NA was also 
demonstrated. Then Scott and Mattey (72) incubated resting f· butylicum 
cells with 14c-formate and found nearly all of the radioactivity in 
carbon 6 of nicotinic acid. The role of N-formyl-1-aspartate as a 
precursor to nicotinic acid was postulated when the compound gave 
enhanced rates of NA synthesis over rates for formate and 1-aspartate 
14 
and when carbons 2, 3, 6, and 7 of NA were labeled from C-N-formyl-1-
aspartate (73, 74). Also in cell extracts, a specific formylation 
inhibitor shut off NA synthesis from formate and aspartate, but not from 
N-formyl-L-aspartate. The origins of carbons 4 and 5 of nicotinic acid 
in this organism are not known. 
+ A different pathway, therefore, exists for NAD biosynthesis inf· 
butylicum, involving N-formyl-L-aspartate and likely a 2-carbon compound, 
Presumably, QA is an intermediate in this process, but specific evidence 
is not yet available, 
In Serratia marcescens, an organism more nearly like~, coli, the 
only work done indicates a different labeling pattern in nicotinic acid 
f 14c . 'd rom -aspartic aci . In cell suspensions, Scott and Hussey (57) 
observed incorporation of the aspartate carbons 3 and 4 into the 
13 
carboxyl group and ri~g of NA, respectively. However, carbon 2 from 
aspartate chiefly labeled the carboxyl group of NA, resulting in the 
contribution of two carbons of aspartate to one carbon of NA. It was 
suggested in this work that at some stage carbons 2 and 4 of aspartate 
become equivalent and one is lost. If this or a similar explanation is 
correct, nicotinic acid formation in Serratia marcescens represents a 
third distinct de !!.2Y£ pathway for NAD+ biosynthesis in microorganisms 
without the tryptophan-niacin relationship. 
The yeast Saccharomyces cerevisae (.§_o cerevisae) is a facultative 
organism and utilizes the tryptophan-nicotinic acid pathway under 
aerobic conditions, but not under anaerobic conditions (47), It was 
shown that anaerobically, the tryptophan pathway cannot operate, but that 
aspartic and glutamic acids are effective precursors of nicotinic acid. 
Aerobically, though, these dicarboxylic acids are not good precursors of 
NA. + Quinolinic acid was also shown to be a precursor of NAD and common 
to both pathways in yeast. 
Formation of Nicotinic Acid in Higher Plants 
Studies on the precursors of nicotinic acid in higher plants were 
primarily carried out as part of the investigation of biosynthesis of 
the alkaloids nicotine, anabasine, and ricinine, which derive their 
pyridine ring from nicotinic acid, Nearly all such studies have been 
carried out with labeled compounds in intact plants, with subsequent 
isolation of labeled productso The most recent review of this work was 
made by Leete in 1969 (75). 
Tryptophan or 3-hydroxyanthranilic acid could not serve as a 
precursor of the pyridine nucleus in peas, corn, or soybeans (58, 76), 
14 
nor could 7a-14c-tryptophan be shown to form nicotine in Nicotiana 
tabacum or Nicotiana rustica (58, 77). Ricinine was not labeled from 
7a-14c-tryptophan in Ricinus communis (castor bean plant) (78). There-
fore, work was begun to discover the precursors of NA in these species. 
The incorporation of 2-14c-acetate into nicotine and anabasine in 
Nicotiana species was the first demonstration of de ~ biosynthesis of 
the pyridine ring in plants (79, 80). The use of acetate labeled in 
carbon 1, however, did not result in labeled alkaloids. Another study 
(81) 14 demonstrated C incorporation into the pyridine ring of nicotine 
from 14 14 14 2- C-propionate, 1,3- C-glycerol, and 2- C-glycerol. Formation 
of the a~pyridone ring of ricinine was reported to occur from 2-14c-
acetate, 2,3-14c-succinate, l,3-14c-glycerol, and 2-14c-glycerol (78, 
82, 83, 84). 
When better chemical methods for carbon-by-carbon degradation· of 
nicotinic acid and these pyridine alkaloids were developed, much more 
information could be obtained from labeling studies. Yang, ~al. (85) 
and Gritfith and Byerrum (86) found glycerol to be a precursor of car-
bons 4, 5, and 6 of the pyridine ring of nicotine. Glycerol shows 
similar incorporation into ricinine (59) and anabasine (87). Carbons 2 
14 
and 3 of the pyridine ring are labeled when 2,3- C-succinate is used in 
the formation of nicotine (86) and ricinine (59, 88, 89). Other 
dicarboxylic acids showing incorporation were 3-14c-aspartic acid and 
14 14 14 4- C-aspartic acid in ricinine (90) and 3- C-aspartate and 3- C-
malate in nicotine (91). 
These numerous isotopic precursor experiments indicate the source 
of carbons 4, 5, and 6 in higher plants is a non-symmetrical 3-carbon 
15 
compound closely related to glycerol. The remaining carbons of NA 
appear to be derived from a 4-carbon dicarboxylic acid that.is metabol-
ically close to succinic acid (76). The specific precursors may be 
aspartic acid and glyceraldehyde-3-phosphate. Fleeker and Byerrum (92) 
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showed better incorporation of D-3- C-glyceraldehyde than of glycerol 
in Nicotiana rustica. Incorporation studies utilizing labeled aspartic 
acid, however, have been difficult to interpret, due to long incorpora-
tion times and rapid aspartate metabolism in the plants (76). The 
source of the nitrogen of the pyridine ring in Ricinus communis 1.· has 
15 14 15 been studied utilizing N-aspartate, C, N-aspartate (59, 90), and 
other nitrogen sources (93) with unclear results. Figure 2 indicates 
some incorporation patterns. 
Quinolinic acid was found to be a precursor of nicotinic acid in 
corn (94) and castor bean plants (95). Also, QA is an intermediate in 
the de novo formation of nicotine in tobacco plants (85, 96) and 
ricinine in the castor bean plant (94). 
Although much work has been done to determine the precursors of the 
nicotinyl portion of these pyridine alkaloids, exact pathways of bio-
synthesis have not been established, Confirmation of aspartic acid and 
glyceraldehyde-3-phosphate as the precursors awaits cell-free studies 
and purification of enzyme systems. Present knowledge indicates the.de 
+ ~ pathway of NA and thus NAD biosynthesis in higher plants may be no 
different than the pathway in_!. coli and M. tuberculosis. 
Excluding the tryptophan-niacin pathway, then, two and perhaps 
+ three pathways for de ~ NAD biosynthesis in higher plants and micro-
organisms present themselves. The pathway found in _!. coli may be the 
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one common to most plants and bacteria, but much more investigation is 
necessary to show this. 
Pathways of Pyridine Nucleotide Metabolism 
In addition to the de ~ pathway for the biosynthesis of 
quinolinic acid, most organisms can also utilize NA or NAm or both to 
synthesize NAD+ (97). The pathways and interconversions involving these 
nicotinyl derivatives have been the subject of much study. 
After identification of intermediates of these pathways using human 
erythrocytes, rat liver, and yeast, Preiss and Handler (98, 99) 
described enzyme activities that led them to propose the sequence 
+ + + NA + NAMN + dNAD + NAD for the synthesis of NAD , based upon the fol-
lowing reactions observed:. 
NA + PRPP + NAMN + PPi 
NAMN + ATP + dNAD+ + PPi 
+ + dNAD + ATP + glutamine + NAD + AMP + PPi + glutamate 
These reactions were later established in other tissues (100) and their 
sequence became known as the Preiss-Handler pathway. 
+ Cyclic schemes for the utilization of exogenous NA and for NAD 
metaboli~m were suggested by Joshi and Handler (101) and Sarma, ~.!!· 
(102). These were founded upon the enzyme activities then known to 
exist for these pathways and upon the belief that the nicotinyl portion 
from the de ~ biosynthetic pathway entered into the cyclic reactions 
as nicotinic acid. However, with the discovery that.the de novo pathway 
enters at the NAMN level through QA by the QRTase enzyme (40, 61, 94, 
103), Gholson (100) summarized these interconversions as the more 
general pyridine nucleotide cycle existing in most organisms. 
The Pyridine Nucleotide Cycle in E. coli 
In .§_. coli, the Preiss-Handler pathway for the utilization of 
exogenous NA and NAm was demonstrated in 1961 when Imsande (104) 
reported four enzyme activities in extracts of§.. coli K-12: 
(1) 
(2) 
(3) 
(4) 
Nicotinamidase 
NAMN pyrophosphorylase 
+ dNAD pyrophosphorylase 
+ NAD synthetase 
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Thus, the sequence of NAm +NA+ NAMN 4 dNAD+ + NAD+ was established in 
§_, coli. Andreoli ~ al. (61) detected a new enzyme activity in K-12 
extracts that would convert QA to NAMN, without the involvement of NA as 
an intermediate. This enzyme became known as quinolinate phosphoribosyl-
transferase (QRTase). Nicotinic acid was, however, confirmed to be a 
+ necessary intermediate in the formation of NAD via the Preiss-Handler 
pathway in studies utilizing mutants that cannot convert N.Am to NA. 
(105) • Meanwhile, NAD + syn thetase, which forms NAD + from dNAD +, was 
purified from_§.. coli B cells and studied (106), + Also, NAD pyro-
+ phosphorylase and deamido NAD pyrophosphorylase, which convert NMN and 
+ + NAMN to NAD and dNAD , respectively,were observed to apparently be one 
enzyme having both functions in§.. coli B (107). The enzyme DNA ligase 
(27, 28) was discovered and shown to possess high activity in§_. coli 
(108), catalyzing the hydrolysis of NAD+ to NMN. NAD+ is converted to 
NADP+ by NAD+ kinase (159). Table II includes these enzyme activities 
and their reactions. 
The proposal of the pyridine nucleotide cycle in 1966 (100) fur-
nished a frame of reference with which to evaluate these reported enzyme 
activities. Figure 3 outlines the cycle and its enzymes. If the cycle 
Enzyme 
Quinolinate 
Phosphoribosyl-
transferase 
dNAD+ (NAD+) 
Pyrophosphorylase 
NAD Synthetase 
DNA Ligase 
NMN Glycohydro-
lase 
Nicotinamide 
Deamidase 
NAMN Pyrophos-
phorylase 
TABLE II 
ENZYMES RELATED TO PYRIDINE NUCLEOTIDE METABOLISM IN E. COLia 
Other Names 
QRTase; NAMN 
Pyrophosphorylase 
(carboxylating) 
NAMN (NMN) 
Adenyltransferase 
DNA-joining enzyme; 
Polynucleotide + 
Synthetase (NAD ) 
NMNase 
Nicotinamidase; 
Nicotinamide 
Amidohydrolase 
NRTase; NA Phospho-
ribosyltransf erase 
Enzyme 
Commission Noo 
E.C. 204.2.19 
E.C. 2. 7. 718 
(EcC. 27.7.1) 
E.C. 6.3.1.5 
E.G. 6.5.1.2 
E.C. 3.5.1.19 
E. C. 2. 4. 2 .11 
E. coli 
Strain 
K-12 
K-12, B 
K-12, B 
C64, B, 
1100 
K-12 
K-12 
K-12 
Reaction Catalyzed 
QA + 5-PRPP + NAMN + 
PPi + co2 
NAMN + ATP + dNAD+ + PPi 
(NMN + ATP + NAD+ + PPi) 
Reference 
(61) 
(104, 107) 
dNAD+ + ATP + NH3 + NAD+ (104, 106) 
+ AMP + PPi 
NAD+ + (deoxyribonucleo-
tide) + (deoxyribo-
n 
nucleotide) + NMN + AMP 
+ (deoxyrib~nucleotide) 
m+n 
(27, 28, 
181) 
NMN + H20 -r NA + Ribose- (109) 5-P m 
NAm + H2o +NA+ NH3 (104, 168) 
NAMN + PPi + NA + 5-PRPP (104) 
...... 
00 
Enzyme Other Names 
NMN Amidohydrolase NMN Deamidase 
+ NAD Glycohydro- + + NAD ase; NAD 
lase Nucleosidase 
+ NAD Pyrophospha- + NAD Phospho-
tase hydrolase 
a(25) 
TABLE II (Continued) 
Enzyme 
Commission No. 
E.C. 3.2.2.5 
E. C. 3. 6 .1. 22 
E. coli 
- --Strain 
K-12 
(RS 126) 
not found 
not 
reported 
Reaction Catalyzed 
NMN + H2o -+ NAMN + NH3 
NAD+ + H2o -+ NAm + ADP-
Ribose 
NAD+ + H2o -+ NMN +AMP 
Reference 
(115) 
(109) 
(110) 
I-' 
"' 
( 3) 
~ dNAD NAO+ 
L - Aspartate ffil,1£]? 
+ 
(tj? 
~ 
-- ___::... QA 
(2( (8) \4) 
~ -- -NMN NAMNL___ --
DHAP ( I ) 
c\(ID[fil? ~ }5) 
NA NAm 
( I ) Quinolinate Phosphoribosyl tronsferose 
(2) dNAD Pyrophosphorylase 
(3) NAO Synthetase 
( 4) DNA Ligase 
( 5) NMN Glycohydrolase 
( 6) Nicotinamide Oeamidase 
(7) NAMN Pyrophosphorylase 
(8) NAO Glycohydrolase 
( 9) NMN Amidohydrolase 
Known Control 
[ij] 
1£1 
~ 
See Table II for complete enzyme reactions. 
(6) 
Points: 
Repression 
Feedback Inhibition 
Allosteric Effector 
Figure 3. The Pyridine Nucleotide Cycle in E. coli 
l'V 
0 
does operate in.§_. coli, at least these three conditions must be met: 
(1) the necessary enzyme activities for each conversion must be 
+ observed, (2) production of NAD from exogenous niacin must be found 
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(i.e., the 11salvage pathway" must operate), and (3) turnover, or cycling 
of the intermediates in the pathway,must be demonstrated. 
Table II lists the enzymes for pyridine nucleotide interconver-
sions that have been detected to date. All tne enzymes necessary to the 
+ cycle have been reported except one, which is NAD glychoydrolase. This 
+ enzyme cleaves NAD at the N-glycosyl bond.to produce ARPPR and NAm and 
has not yet been demonstrated in.§.. coli.in an unhibited or detectable 
form (109). If the cycle is to operate, then, somehow the cell must 
+ + convert NAD to NAm, NAD could be cleaved to NMN by an enzyme such as 
+ NAD pyrophosphatase (110), but no report of this enzyme in§.. coli has 
been made, either. However, DNA li~ase does exist in this organism (27, 
+ 28) and produces NMN from NAD • Thus, the recent report of Andreoli, 
~al. (109) of a membrane-localized,NMN-specific glycohydrolase pre-
sents the distinct possibility that this part of the pyridine nucleotide 
+ + cycle proceeds through the steps NAD + NMN + NAm, and not NAD + NAm 
directly. If this is correct, these interconversions prescribe that a 
different form of the pyridine nucleotide cycle operates in .§_. coli com-
pared to other microorgani~ms (see below). 
Other evidence for the operation of the cycle consists of .the dem-
+ onstration that NAD can be formed from NAm or NA, with NA as a required 
+ intermediate (100, 105), and that exogenous NAD seems to first be 
cleaved and routed through the salvage pathway in.order to be utiiized 
+ to make cellular NAD (111). Direct evidence for turnover was obtained 
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in studies in which mutants without nicotin•mide deamidase (pnc A 
mutants) excreted NAm into the media when grown on NA (112). Thus, NA 
had to proceed through the cycle in order to form the excreted NAm. 
Also, turnover evidence has been obtained recently from in ~ studies 
in exponentially growing !· .££.!.!. using pulse-labeling of precursors 
(113, 114, 115). 
A new scheme for pyridine nucleotide interconversions.has been pro-
posed by Olivera, et al. (115), based upon such turnover data. In the 
scheme, two cycles operate, one for NAm interconversions and one for NA 
interconversions exclusive of NAm. + NAD is a central intermediate of 
both cycles, Although intermediates have not been completely demon-
strated, an NMN deamidase has been found (115) that would allow NMN 
interconversions exclusive of NAm. Also, these cycles would involve DNA 
+ ligase and dNAD pyrophosphorylase (see Table II) activities. 
This detection of NMN deamidase in !· coli opens up the possibility 
of a "short cut" across the cycle by the conversion of NMN to NAMN dir ... 
ectly, bypassing NAm and NA. Then, with the operation of DNA ligase and 
NMN glycohydrolase, the pattern would actually consist of a small cycle 
enclosed by a larger cycle containing NA and NAm. The cycle and its 
enzymes are depicted in Figure 3. Quinolinic acid is the precursor of 
NAMN and the entry point into the cycle for de ~ biosynthesis. The 
exogenous precursors NA and NAm are incorporated into the cycle via the 
salvage pathway, from NAm ~NA~ NAMN (Figure 3). 
Evidence, then, indicates that the pyridine nucleotide cycle does 
function in E. coli, although the exact form of the cycle needs further 
clarification. 
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Pyridine Nucleotide Interconversions in Other 
Microorganisms and Plants 
In other microorganisms and plants, all the enzymes have been 
detected for the cycle as it was originally proposed. Table III indi-
cates the enzymes and organisms in which they have been found to date. 
Perhaps the most widely studied is nicotinamide deamidase, a key enzyme, 
i h ili i f NAm d NAD+, i h 1 i i n t e ut zat on o exogenous an assum ng t e eye e s n 
operation. NAD+ glycohydrolase appears to be.widely distributed in 
+ bacteria •. It is interesting to note that the NAD glycohydrolase of. 
Streptococcus species, in which the enzyme is excreted into the m~dia, 
has recently been demonstrated.to be.identical with streptolysin-0, an. 
extracellular prote:J.n with hemolytic activity produced in these bacteria · 
(151, 152)0 
+ Also, NAD pyrophosphatase has been found in several species and 
NMN amidohydrolase (NMN deamidase), newly detected in.§_. coli, is pres-
ent in other bacteria. QRTase, included because of its role in linking 
the £.!. ~ pathway to the cycle, is also existent in many organisms. 
It would appear, thei;i, that most of these enzyme activities are 
ubiquitous in living systems, which implies the pyridine nucleotide 
cycle may function in all systems. Known.exceptions are some 
Lactobacilli and Leuconostoc mesenteroides ·(121), which requite NA or 
NAm fer growth and seem to convert one of these to NAD+ by a simple 
pathway. 
Little work has been done· on the pathways of pyridine nucleotides, 
in plan~s, but quinolinic acid has been shown, to be a precursor of NA 
and NAMN in corn and castor bean .. plant;s and a precursor of ricinine, 
also in.the castor bean plant (94). In addition, the intermediates and 
TABLE III 
PRESENCE OF ENZYMES OF PYRID,INE NUCLEOTIDE METABOLISM 
IN OTHER MICROORGANISMS AND PLANTS 
Organism 
Quinolinate Phosphoribosyltransf erase 
Mycobacterium species 
Pseudomonas species 
Clostridium butylicum 
Astasia longa 
~mays 
Ricinus conununis 
+ dNAD Pyrophosphorylase 
yeast 
Mycobacterium tuberculosis 
Astasia longa 
NAif Pyrophosphorylase 
Leuconostoc mesenteroides 
Lactobacillus species 
NArt Synthetase 
yeast 
Mycobacterium tuberculosis 
Astasia longa 
Nicotinamide Deamidase 
Aspergillus niger 
Torula cremoris 
F'lavobacterium peregrinum 
Saccharcmyoes cerevisae 
Neurospora crassa 
Micrococcus lysodeikticus 
Claviceps purpurea 
Lactobacillus species 
Streptococcus faecalis 
Mycobacterium species 
Other bacteria 
NAMN Pyrophosphorylase 
Bacillus subtilis 
Reference 
(116, 117) 
(103, 118) 
(55) 
(120) 
(94) 
(94) 
(99) 
(117) 
(120) 
(121) 
(121) 
(99' 122) 
(11'1) 
(120) 
(123) 
(101) 
(124) 
(125) 
(126, 127) 
(128) 
(46) 
(121, 131) 
(131) 
(129' 130) 
(134) 
(135' 136) 
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TABLE III (Continued) 
Organism 
yeast 
Salmonella typhimurium 
Serratia marcescens 
Torula cremoris 
Tetrahymena pyrif ormis 
Mycobacterium tuberculosis 
Astasia longa 
Leuconostoc mesenteroides 
Lactobaccillus plantarum 
Lactobacillus casei 
NMN Amidohydrolase 
Propionibacterium shermanii 
C1ostridium sticklandii · 
Azotobacter .vinelandii 
+ NAD Glycohydrolase 
Aspergillus niger 
Mycobacterium tuberculosis 
Pseudomonas putida 
Streptococcus species 
Neurospora crassa 
Mycobacterium butyricum 
Bacillus subtilis 
Claviceps purpurea 
NAD+ Pyrophosphatase 
Clostri.dium butylicum 
Proteus vulgaris (NADP+) 
dNAD+ Pyrophosphatase 
Clostridium butylicum 
Reference 
(137' 138) 
(135) 
(135) 
(135) 
(135) 
(139) 
(120) 
(125, 121) 
(121) 
(121) 
(140) 
(141) 
(142) 
(123) 
(143) 
(144) 
(145) 
(146) 
(147) 
(148) 
(46) 
(149) 
(150) 
(149) 
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the operation of the pyridine nucleotide cycle have been implicated in 
the biosynthesb of ricinine (153, 154). Studies with barley leaves 
(155) and wheat leav.es (156) indicate that; the .Prei~s-Handler pathway 
occurs in these organisms. 
If the pyridine nucleotide cycle does function in th~se micro-
organisms and plants, .as the intermediates and enzyme activities indi-
cate, it remains to be shown th.at the salvage pathway can operate and 
+ that turnover of NAD occurs in vivo. 
---. 
+ Regulation of NAD Biosynthesis in§.. Coli, 
Regulation of enzyme synthesis, enzyme activitie,s, and int.ra- , 
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cellular product levels is an important aspect .of biosynthetic pathways. 
In genE!ral, the rate of coenzyme synthesis is about one one-thausandth 
of the rate of synthesis of major metabolites, suc.h as most, aminG> acids 
and nucleic acid bases. Coenzymes, however, are reused many times, thus 
requiring much lower cellular levels and correspondingly lower rates of 
synthesis. + Total NAD (oxidized and reduced) levels have been deter-
mined in E. coli and results range from 0.1 to 1.0 mM in the cell, 
depending upon nutritional and growth conditi9ns. Consequently, contra! 
mechanisms must operate to create and maintain such !eve.ls. 
+ One point of view that can be taken of control of NAD biosynthesis 
+ + is based upon the key reles of NAD and NADP in energy preduction and 
biosynthesis (157). Since such processes are so essential to the cell, 
+ careful control of NAD synthesis and degradation would be expected so 
that these ceenzymes are always present when. needed, but net at exces-
sively high levels. 
On the other hand, regulation of coenzyme production may be con-
sidered to be loosely controlled compared to control of production of 
the major cell metabolites. As Tritz and Chandler (158) have pointed 
out, a high proportion of overproduction (and thus excretion) of NAD+ 
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precursors can occur in cultur.es of .§_. coli mutants, It would seem that 
+ the cell is indiscriminately synthesizing NAD and wasting it, reflect-
i.ng poor control of its synthesis. However, this excretion has a 
maximum rate, as does the excretion of major cellular metabolites, which 
implies an even more finely controlled system for NAD+ biosynthesis, 
since NAD+ levels are much lower than those for major metabolites. 
NAMN Pyrophosphorylase 
Perhaps the first enzyme of NAD + metabolism to be implicated .in 
control was NAMN pyrophosphorylase, Imsande and Pardee (159) checked 
the effect of supplemental NA or NAD+ in the growth medium of NA 
auxotrophs of E, coli upon the enzyme activities catalyzing the steps 
+ -7 from NA to NAD , They found that above 5 x 10 M supplemental NA or 
NAD+, repression of NAMN pyrophosphorylase biosynthesis occurred. They 
+ also checked for feedback inhibition in extracts by NAD and found none. 
Further work (135, 160, 161) confirmed the repression-depression regula- . 
tion of NAMN pyrophosphorylase by NMN as well as NA and NAD+. · Compounds 
that fail to show feedback inhibition are NA, NAD+, NAMN, and NAm at 
concentrations up to 1 x 10-3 Min E, coli extracts (160). Recent in 
vivo studies (114) have confirmed the regulatory nature of NAMN 
pyrophosphorylase by showing that the rate of pyridine nucleotide bio-
synthesis is determined by the rate of conversion of NA to NAMN in 
cultures in which the concentration of exogenous niacin is 10-5 M or 
greater. 
Repression of NAMN pyrophosphorylase has also been demonstrated 
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in Salmonella typhimuriurn (135), but not in Senatia marcescens, !· 
subtili.s, !a megaterium, Torula cremoris, Astasia longa, or Tetrahymena 
pyriformis (120, 135, 160), 
ATP (or another nucleoside triphosphate) is an absolute requirement 
for NAMN pyrophosphorylase activity in all of the above species (135, 
138) except Astasia longa, in which the enzyme is ATP-independent (106), 
l.n some mammalian systems, ATP is known to ae:t as a positive allosteric 
modifier of NAMN pyrophosphorylase (162). A similar role for ATP has 
been described for Bacillus subtilis (163, 164), thus forming a cross-
linked control system for the rate of cell metabolism (NAD-t· levels) and 
the rate of energy production (ATP levels), The presence of such a 
control system in. !· coli has been suggested (164, 165), based partially 
upon the ATP level of intact cells, which is apparently rate-limiting in 
the NAMN pyrophosphorylase reaction (166), 
Nicotinamide Deamldase 
Possible regulatory significance has been attributed &o the first 
enzyme in the salvage pathway, nicotinamide deamidase, Calbreath and 
Joshi (167) reported feedback inhibition of the deamidase in crude 
extracts of several microorganisms, including §_, colL The presence of 
8 rnM NAD+ caused up to 93% inhibition of the deamidase actlvity, depend-
ing upon substrate (NAm) concentration, This may or may not be actual 
feedback inhibition, since it is known that exogenous NAD+ is utilized 
first by conversion to NAm in intact cells (111), The continued 
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operation of that enzyme system (NAD+ ~ NAm) in crude extracts would 
result in isotope dilution of the 7-14c-NAm assay substrate used by the 
unlabeled NAm deri.ved from the added NAP+. More rec.ently, McLaren, _il 
.al,. (114) indicated that.~vivo there is no regulation of the rate of 
conversion of NAm to NA (Nicotinamide deamidase activity). They 
observed the rapid uptake of exogenous NAm by the cells and its conver-
sion .to NA, with NA excretion occurring as long as NAm is available. 
Also,. the study done by Pardee, et al. (168) showed no change in 
+ deamidase activity of cells grown on media c.ontaining NAm, NA, NAD , or 
NADP+ at various concentrations in the 10-7 to 10-S M range. These 
studies utilized an assay very similar to ·that of .Calbreath and Joshi, 
but with a highly purified deamidase preparation .from!· coli K-12, 
which. would eliminate the potential problem of isotope dilution by 
production of unlabeled substrate from the exogenous compound. 
+ Inhil?iticm of nicotinamide .deamidase by NAD has been observed in 
extracts of Clostridium acetobutylicum, !• stearothermophilus, 
Mi,crococcus lysodeikticus, Torula c·remoris, and s. cerevisae (167). In 
a purified preparation from Torula cremoris (101), NAD+ and NADP+ were 
observed to be noncompetitive feedback inhibitors of the enzyme. Inde-
+ -4 pendent from this inhibition, concentrations of NAD of 10 Min the. 
media of Torula cremoris repressed production of nicoti.namide deamidas.e 
up to 50%. 
+ NAD Glycohydrolase 
+ Although not known to. exist in E_o coli, NAD glycohydrolase has 
been shown to have regulatory properties in several microorganisms. 
Partially purified NAD+ase from M. tuberculosis is known to possess a 
heat-labile inhibitor that complexes with the enzyme to cause loss of 
activity (148, 169). The protein inhibitor exists in excess in crude 
extracts and has been purified and characterized. (170). Heat-labile 
protein inhibitors of NAD+ glycohydrolase have also been found in M. 
butyricum (171), Pseudomonas putida (144), and!· subtilis (148). In 
addition, each enzyme associated with a heat-inactivated inhibitor is 
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itself heat-stable (144). This type of inhibitor-enzyme complex for 
NAD+ glycohydrolase could very possibly play a role in regulating turn-
over and levels of NAD+. Perhaps this occurs through inhibition of the, 
formation of the enzyme-inhibitor complex by high concentrations of NAD+ 
(144). 
No basis, however, exists for this mechanism to function in!· 
coli, Much effort has been put into detecting NAD+ glycohydrolase in an 
active form, but results have been negative (109). If NAD+ glycohy-
drolase. exists in !· coli, the reason for the failure in detecting it 
may well. be a tightly bound inhibitor. Alternatively, .further charac-
terization of the recently reported NMN glycohydrolase (109) may reveal 
such an enzyme-inhibitor complex that may function in regulation of NAD+ 
or NMN levels and cycle turnover. 
Enzymes of the de Novo Pathway 
In the de !!2Y2. pathway for NAD+ biosynthesis, several studies on 
control have·been made since it was determined QA is an intermediate and 
that it enters the cycle at NAMN (61), Quinolinate phosphoribosyltrans-
£erase is repressed in !.· subtilis and ]l, megaterium when these organ-
isms are grown on media containing 10-5 Mor higher NA (136, 160, 165). 
No repression of QRTase has been observed under these conditions in E. 
coli (160, 165). Feedback inhibition could not be demonstrated in B. 
subtilis using NA, NAD+, or NADP+ (136), It has been reported in!· 
coli that pyridoxal-phosphate is a strong inhibitor of QRTase (158), 
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The enzymes for QA biosynthesis in !· .£.2.1!. do seem to be controlled. 
by repression-derepression. Using mutants lacking QRTase, NA concentra-
tions of 1 x 10-5 Mor higher in the.media effectively prevented 
synthesis of enzymes for QA synthesis (160, 165), It is possible that 
NAm and NAD+ at 5 x 10-6 M can also effect this repression (64). 
Inhibition of QA synthesis in extracts by addition of NAD+, 
pyridoxal-phosphate, and pyridoxamine-phosphate was demonstrated, using 
concentrations of 3.33 mM in crude extracts (64), A slight inhibition 
was also noticed for NAD+ at 0,5 mM, which is near the proposed concen-
tration for NAD+ in!· coli cells (104). In the same system, NA, NAm, 
and NADP+ did not block QA synthesis in crude extracts. When these 
+ compounds and NAD were added to resting celi cultures, reduction in QA 
synthesis was observed in the resulting crude extracts, implying the 
conversion of these compounds to NAD+ before extracts were assayed (158). 
Recent genetic work (158) suggests the existence of a gene (nad .!~) 
which may be responsible for the regulation of the two ger1es (nad fl and 
nad .!!) coding for enzymes of quinolinic acid biosynthesis, In vitro 
complementation analysis has suggested this gene affects the expression 
of the nad fl and nad 1?_ genes, Perhaps this is the mechanism by which 
the repression of the QA biosynthesis enzymes occurs, 
Another possible control mechanism is at the cell membrane of E, 
coli. Olivera ~al. (114) have shown that exogenous NAm is taken up 
+ rapidly into the cell and metabolized to NAD ) whereas NA uptake becomes 
+ ' -6 
rate-limiting to NAD synthesis at NA concentrations below 8 x 10 M. 
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Accumulation of NA from the media has been reported (159), but recent 
evidence (114, 172) does not support the existence of an active trans-
port mechanism in the membrane for niacin, It is suggested that the 
charged NA molecule is less permeable to the membrane than NAm. 
NAD+ biosynthesis in _!. coli, then, appears to be regulated by 
known types of mechanisms, including repression-derepression, feedback 
inhibition, and possibly allosteric modification, The operation of 
these mechanisms is only partially understood and represents a complex 
control system that is similar but not identical to the control of NAD+ 
biosynthesis in other microorganisms. Figure 3 indicates the known 
points of control of NAD+ metabolism in E. coli. 
The Quinolinate Synthetase System of E, Coli 
. 14 After Ogasawara, ~ al. (62) demonstrated incorporation of c-
aspartate into QA in .!· coli extracts, work began to further elucidate 
the enzymes, precursors, and intermediates of the de ~pathway. 
Mutants known to be blocked in the conversion of QA to NAMN were mapped 
by Tritz, et al. (173). These QRTase mutants (nad £gene) were very 
useful in studying the de ~pathway" When such mutants were grown 
with NA under conditions of derepression, they produced a several-fold 
excess of QA and excreted it into the medium (174). Further genetic 
characterization of the pathway using in vitro complementation estab-
lished that the nad f:.. and nad ! genes code for enzymes synthesizing QA 
(175, 176) and that nad B:_ is likely a regulatory gene (158), 
Chandler and Gholson (177) developed an assay for isolating and 
measuring 14c-quinolinic acid synthesized in crude extracts of nad .£ 
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mutants and carried out numerous studies on the quinolinate synthetase 
system (62, 63, 64, 178). Then Suzuki, et al. (179) achieved partial 
purification of two soluble protein fractions, one prepared from an§.. 
coli K-12 nad A mutant and one from a nad ! mutant, Using the.se frac-
tions., the triose-phosphate suggested by Chandler, et al. (63) as the 
3-carbon precursor of QA was confirmed and specifircally identified as 
dihydroxyacetone-phosphate. Furthermore, FAD was discovered as a neces-
sary cofactor and the pH optimum for QA synthesis in vitro was shown to 
be 8.0 to 8.5. 
A new report from Kerr and Tritz (180) shows evidence for c:ross-
f eeding of a nad A mutant by a nad ~ mutant grown simultaneously in 
liquid cultures, This indicates that the proi:ein present in the.nad ! 
mutant extracts is the first in the sequence and produces and excretes 
the intermediate 11prequinolinic acid 11 • Other combinations of nad f:., 
nad ~' and nad f., however, show no cross-feeding. 
On the other hand, extensive work by Chandler (178) in both in 
vivo and in vitro systems failed to show any evidence of an inte.rmedi-
ate that accumulates even to the level of 3% of the QA produced. The 
intermediate may not be permeable to the cell membrane, or it may be 
enzyme-bound, or it may be unstable, or it may not exist at all. What-
ever the case, much more work remains to be done before the existence 
or non-existence of an intermediate in QA biosynthesis is completely 
understood. 
The protein fraction from the nad ,!! mutant, the A protein, is heat-
stable and was purified about 40-fold, The protein from the nad ! 
mutant, the B protein, was purified about 15-fold. Molecular weights 
and other properties of the two proteins are different and both are 
required for the synthesis of 14c-QA from 14c-aspartate (179). Figure 
4 depicts the QA synthetase system as it is now known. 
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For any further work on the intermediate, kinetics, regulation, or 
enzyme mechanisms of the ~ B.2Y£. biosynthesis of QA, a highly or 
completely purified preparation of at least one of the proteins is 
required. Therefore, this work began at this! point, with the objective 
of purifying the B protein produced by the nad A mutant PA-2-18 and of 
further characterizing the quinolinate synthetase system using more 
highly purified enzyme preparations from]_. coli K-12. 
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CHAPTER III 
METHODS AND MATERIALS 
Cultures 
Mutant strains of E_. coli K-12 requiring niacin and other growth 
factors were routinely marker checked to insure appropriate strains (see 
Table IV) were being used.. Stock c~ltur.es were maintained in nutrient 
agar stab cultures and new nutrient. agar plate cultures used for inocula-
tion were prepared mon~hly. Genetic characteristics of mutants used in 
these studies are listed in Table IV (108). Cells were grown in the 
minimal medium of Yates and Pardee (182). Additions to the medium were 
-7 -6 -3 5 x 10 M NA, 2 x 10 M thL!lmine, and 1 x 10 M concentrations of the 
appropriate amino acids for each strain, All cultures were grown at 37oc 
with vigorous shaking or aeration for 12 to 14 hours. When only crude 
extracts were checked for enzyme activities, 100-ml cultur.es were grown 
using a 5-ml inoculating culture. These were harvested by centrifuga-
tio~ at 8000 x g for .15 minutes and yielded five to seven grams wet 
weight of cells for each 100-ml culture. 
For enzyme purification, 10-liter cultures were grown using a New 
Brunswick Fermenter and successive inoculation cultures of 5 and 100 ml, 
Cells were harvested with a Sharples centrifuge. The wet cell paste was 
washed by resuspension in 0.9% NaCl (4 ml per gram wet cells) and 
centrifuged at 10,000 x g for 15 minutes. After weighing, cells were 
ste.red at -15°C. PA-2-18 and SB~16 10-liter cultures yielded 50 to 60 
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Strain Sex 
-PA-2-18 F 
-AT-11-23 F 
SB-16 Hfr 
W-3899 F -
E-126 F+ 
SB-99 Hfr 
-W-4516 F 
AT-13-3 F+ 
a(l08) 
TABLE IV 
GENETIC CHARACTERISTICS OF MUTANTS OF E. COLI K-12a 
A Phage 
Sensitivity Mutations Present 
- nad A19 arg A, thi, str A, xyl, 
mtl, mal, lac, gal -- -
+ nad A28' thr, leu 
----
- natl B15, met 
- nad B30 
- natl C13 
----
- natl £2..z_, met 
-- ---
- natl C32 
- natl C22, thr, leu 
Stock No. 
(Univ. Texas Houston) 
UTH 4460 
UTH 4455 
UTH 4674 
UTH 4464 
UTH 4673 
UTH 4143 
UTH 4466 
UTH 4678 
l...V 
~ 
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grams and 30 to 40 grams of wet cells, respectively. Activity of QA-
synthesizing enzymes in frozen cells .remained stable up to four months 
or more after harvesting.· 
Nicotinic Acid Concentration 
Since all strains used require nicotinic acid, the optimum NA con-
centration for maximum cell.growth was determined. Twenty-five-ml 
cultures of PA-2-18 were grown at 37°c in sidearm flasks with NA ccm-
centrations from 3 x 10-7 M to 2 x 10-6 M in the media. Cell density 
was checked .at fc:iur hc:iurs, six hours, and eight hours using absorbance 
at 420 nm, as measured by a Coleman. Jr. spectrophotometer. A standard· 
curve c:if A420 versus cell dry weight in mg per ml was prepared. Then 
the.cell dry weight was plotted against the logarithm of the NA concen-
traq.on used, as shown in Figure 5. Such experiments indicated that the 
-7 loweet NA concentration that allows maximum cell growth is 5 x 10 M 
for 25-ml cultures of the PA-2-18 strain. This concentration of NA was 
used in·the. 10-liter cultures of PA-2-18 and SB-16 strains. 
Preparation of Crude Extracts 
The crude extract of ,g_ • .£.ill K-12 PA-2-18 for enzyme purificatfon 
was prepared by suspension of 60 grams of frozen cells in five volumes 
per gram of 0.05 M Bicine buffer, pH 8.0. When a homogenous suspension 
was obtained, a volume of 350 ml was sonicated for 18 minutes in a large 
rosette cell with a Branson sonifier set at 10 D.C. amperes power •. The 
rosette cell was set in an ice bath to maintain the temperature of the 
solution at 0 to 4°c during sonication. The sonicate was centri~uged 
at 40, 000 x g for 45 minutes to remove cell debris, yielding about 325 ml 
-E 
' C' E 
-
Q) 
(.) 
2.4 
2.0 
1.6 
0.4 
0.2 
39 
D 
~--~~--ao--~-o 
~0----0-------u.o---- 4 Hours 
0.3 0.4 0.5 0.6 o.e '1.0 2 
NA CONCENTRATION, MOLAR X 106 
Twenty-five-ml cultures of PA-2-18 were grown at 37°c at NA concentra-
tions from 3 x 10-7M to 2 x 10-6M. Cell density was determined by 
absorbance at 420 nm at 4, 6, and 8 hours and converted to cell dry 
weight. 
Figure 5. Dependence of the Growth of PA-2-18 Cultures on 
the Concentration of Nicotinic Acid in the Media 
of crude extract (supernatant). When. prepared for purification, crude 
extracts of other strains were prepared in an identical manner, except 
that SB-16 cells were suspended in 0.05 M KP04 buffer, pH 8.0, instead 
of the bicine buffer. 
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Routinely, crude extracts of the SB-16 strain were used in smaller 
volumes only as a source of A protein for QA synthesis. Cells were 
suspended in 0. 05 M KPO 4 , pH 8. 0 (5 volumes per gram), and sonicat.ed 15 
minutes at 0 to 4°c using a Raytheon sonic oscillator unit, The sonicate 
was centrifuged for 15 minutes at 20,000 x g. Ten grams of cells 
yielded about 52 ml of crude extract. 
Experiments were conducted with PA-2-18 and E-126 strains to 
determine the optimum length of time and the optimum power (D.C. amperes) 
and 10 to 18 minutes sonication time, depending upon the volume sonicated 
would insure maximum release of active protein with very little dena-
turation. These paramet~rs were employed in all subsequent preparations·. 
of crude extract$. 
Preparation of the A Protein for Assay 
The source of A protein for the QA synthesis assay was the SB-16 
strain. It was partially purified by heat treatment and salt fractiona-
tion before use in the assay. The crude extract, prepared as described 
0 
above, was mixed for five minutes in a 55 water bath and subsequently 
cooled 10 -minutes in a water-ice bath. After centrifugation for 15 
minutes at 20,000 x g, about 50 ml of heat-treated supernatant were 
obtained• Solid ammonium sulfate was added gradually over 15 minutes to 
this supernatant and stirred at 0 to 4°c to reach 40% saturation of 
ammonium sulfate (148). After mixing for 30 minutes, the solution was 
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centrifuged at 20,000 x g for 15 minutes. The supernatant was treated 
with ammonium sulfate in the same manner to bring it to 60% saturation. 
After 30 minutes mixing and 15 minutes centrifugation at 20,000 x g, the 
supernatant was discarded and the pellet was redissolved in 0.005 M KPo4 
buffer, pH 7.5, with 0.05 M KCl (0.2 ml per mg pellet). The solubilized 
pellet containing theA protein was placed in dialysis tubing (boiled 
three times in 1 mM EDTA) and dialyzed 16 hours at 4°c against 1 liter 
of 0.005 M KP04 , pH 7.5, with 0.05 M KCL Thus, the SB-16 40 to 60% 
ammonium sulfate fraction prepared one day can be ready for the QA assay 
the next day. Heat treatment and subsequent ammonium sulfate fraction-
ation results in a seven-fold final increase in specific activity over 
the crude extract, 
Enzyme Assay for Quinolinic Acid Synthesis 
Assay Procedure 
Measurements of the enzymatic activities of the A and B proteins 
were made using the procedures described by Suzuki, ~ aL (65) and 
Chandler and Gholson (177), with some modifications. 
Reaction mixtures were prepared as follows: each assay sample 
contained 0.25 µmole of 1-aspartate, 1 µmole of FDP or DHAP, 0.01 µmole 
FAD, and 30 µmoles of bicine buffer, pH 8,0 (adjusted with KOH) in a 
volume of 0.1 ml. Also, 0,1 ml of a 5µCi-per-ml u-14c-aspartic acid 
solution (specific activity 160 mCi/mMole was added to each tube, 
Enzyme preparations totaling 0.3 ml were added, making final volume in 
the assay tubes of 0.5 ml, unless reagent or inhibitor effects were. 
studied, in which case final volumes were 0,6 ml, 
42 
Assay of the .B protein was carried out using an excess of the A 
protein, such that the amount of B protein activity present limited the 
amount of QA synthesized. Routinely, 0.2 ml of the SB-16 40 to 60% 
anunonium sulfat~ fraction and 0.1 ml of diluted enzyme fraction from 
PA-2-18 were added to each assay tube. These volumes represent 0.3 to 
0.5 mg and 0.01 to 3 mg protein, respectively. When activity of the A 
protein wa$ measured, B protein was added in excess as 0.1 ml of the 0 
to 50% sodium citrate (see Results Chapter) fraction.and the A protein 
was added as a lim~ting amount in a final volume of 0.2 ml. In this 
case, these volumes represent 1 to 2 mg and 0.02 to 4 mg protein, 
respectively. The use of FDP as a substrate necessitates, of cqurse, 
the presence of FDP-aldolase in the assay. This enzyme was present in 
the 40 to 60% ammonium sulfate fraction used in the B protein assay 
(192). 
The assay reaction was begun by adding the protein fraction whi€h 
was to be in excess to the other assay components in order to make a 
complete mixture for in vitro QA synthesis. After gentle mixing, tubes 
were incubated at room temperature (23°C) without shaking. After 20 
minutes, 0.5 ml of 15% perchloric acid was added to stop the reaction •. 
Then 0.5 ml of .2 mM unlabeled QA was added, and the tubes were mixed and 
centrifuged to compact the precipitated protein. After decantation, the 
supernatants were neutralized by addition of 0.5 ml of 2.5 N KOH, with 
subsequent adjustment to pH 7. 0 using indicato.r paper. Tubes were again 
centrifuged to compact the precipitated KC104 • 
These deproteinized and neutralized reaction mixtures were applied 
to 0.7 x 12-cm Dowex l-X8 Cl- columns. Tubes were rinsed with 2 ml of 
deionized water, which was also applied to the.columns. After a wash of 
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15 tnl o~ 0.2 M LiCl, a 6-ml fraction.of 0.6 M LiCl was collected from 
each column. These fractions contained the QA and were applied to 0.9 
+ x 18-cm Dowex 50-X8 H columns. After washing with 20 ml of 0.01 N HCl, 
a 10-ml fraction o~ 0.01 N Rei was collected from each column. These 
14 fractions contained the synthesized C-QA and the unlabeled carrier 
QA, and QA recovery was monitored by checking absorbance at 268 nmeters. 
Collecting .one 10-ml fraction.allowed greater recovery of the t9tal 
14 C-QA synthesized than did the previous method of c9llecting foµr or 
five 2-ml fractions and pooling two of them after checking absorbance. 
Dowex 1 and Dowex 50 columns were regenerated by washing with ten and 
five column volumes of 3 N HCl, respectively, and then with equal 
volumes of deionized water. Figure 6 summarizes the assay procedure. 
Quantification of the Assay 
14 Determination of C-QA synthesized was carried out by counting 
two ml of the 10-ml fraction from Dowex.50 with 10 ml of Bray's 
scintillation cocktl:!-il using a Liquid Scintillation _Counter. The 
samples were counted for 10 minutes each and the cQunts per 10 minutes 
values were converted to ne~ disintegrations per minute by channels 
r~tio quench correction .and backgrounq subtraction, Then the net dpm 
values for each 10-ml Do'l'l{ex 50 fraction were calculated and converted to 
the.number of nanomoles of QA synthesized that they represent. The 
overall specific activity of the u-14c-L-aspartic acid used for incor-
poration, including the unlabeled aspartate in the assay, was 2 µCi per 
µmole. Thus, one µmole of L-aspartic acid incorporated into one µmole 
of quinolinic acid is repr~sented by 2 µCi of 14c-QA, which is.4.4 x 106 
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FDP (DHAP) 
FAD 
0.1 µmole 0 1 1 
0.25 µmole 1 
0.01 µmole • m --------~ 
Bicine, pH 8.0 30 µmoles 
u-14c-L-Aspartate 5 µCi/ml } O l l --------(160 mCi/nunole) • m ~ 
A protein (SB-16 fraction) } 0.2 ml ----------~ 
B protein (PA-2-18 fraction)}o.1 ml ---~----~-
23°c 
Centrifuge and 
Decant 
Adjust to 
pH 7.0 and 
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+ 10 ml Bray's - Scintillation 
~ 
Calculate Units 
Figure 6. Assay Procedure for Quinolinic 
Acid Biosynthesis 
dpm. Thus, 
nmoles QA. synthesized (per 
assay tube) 
= total net dpm ·(per 10-ml fraction) 
4400 dpm/nmole QA 
A unit of enzyme activity, then, is defined as the amount of enzyme 
(either the A or B protein) that can form one nmole of quinolinic acid 
from aspartic acid and DHAP at 23°C in 20 minutes, in the assay system 
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used. Time-course studies (Suzuki, unpublished results) showed that the 
rate of QA synthesis remains constant during this period •. Activity in 
assays is usually expressed as units per ml of undiluted enzyme frac-
tion, thereby including the dilution factor required to make the protein 
assayed (usually B) rate-limiting in the synthesis of QA. Specific 
activity is expressed as units per mg of protein. Protein was.deter-
mined spectrophotometrically by 280/260 nmeter absorbance .ratios and by 
the method of Lowry, ~al. (179). 
The A protein is unstable and decreases to 50% or less of its 
original activity in one week when stored as the 40 to 60% ammonium 
sulfate fraction at -15°c (Suzuki, unpublished observations; see Results 
Chapter), Therefore, the 40 to 60% ammonium sulfate fraction was pre-
pared the day before each time the B protein was assayed. Stabiliza-
tion of the A protein at -15°c with 33% glycerol was achieved, thus 
allowing B protein assays to be carried out with the same 40 to 60% 
ammonium sulfate preparation over about one week. Care had to be taken, 
however, to insure A protein activity was in excess, since assay samples 
could not be quantitatively compared if total units depended upon the 
amount of A protein present and not the amount of B protein present. 
Hence, fresh preparations (one to four days) of the A protein were 
routinely used. Linear dependence of total QA synthesis on the amount 
of B protein was observed, as discussed in Chapter IV. The B protein 
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activity presented little problem concerning stability when stored at 
high protein concentrations (i.e., 10 to 20 mg per ml) at -1s0 c. Under 
such conditions, the 0 to 50% sodium citrate fraction retained from 50 
to 75% of its original activity after six months. Thus, assay samples 
for A protein activity could be compared quantitatively. 
Preparation of Affinity Columns 
The technique of affinity chromatography was examined for i~s 
value in purification of the proteins of the quinolinate synthetase 
system. Specifically selected ligands were covalently bound to 
agarose,a polygalactan polymer, through coupling reactions with sidearms 
attached to the polymer. These coupling reactions involve formation of 
a peptide bond with the elimination of water, using a carbodiimide 
coupling agent. The two coupling agents used in these preparations were 
1-ethyl-3-(3-dimethylaminopropyl)-carbodiimide (EDAC) and dicyclohexyl-
carbodiimide (DCC), Agarose derivatives with various sidearm functional 
groups are available commercially from Bio-Rad Laboratories and are 
termed Affinose gels. Affinose 102 and 202, containing a terminal amino 
group and a terminal carboxyl group, respectively, in the sidearms, were 
utilized for coupling reactions. Sidearm structures are shown in Figures 
7 and 8. 
Preparation of Carboxyl-Linked Aspartate 
Affinity Gel 
Since L-aspartate is a known substrate for QA synthesis, it was 
checked for its ability to bind the B protein to an affinity gel. The 
general technique employed was patterned after specific procedures 
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described by Cuatrecasas and Anfinsen (183). Affinose 102, an w-
aminoalkyl agarose, was washed with 20 volumes of 0.1 M NaCl and then 
deionized water to remove sodium azide (a bacterial growth inhibitor) 
from the gel. To 10 ml (packed volume) of the gel, 0.5 mmoles of 
unlabeled L-aspartate and 0.44 µCi of u-14c-L-aspartate were added. 
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The labeled aspartate served to monitor the extent of coupling obtained 
by counting the radioactivity of the gel. The resulting 20-ml solution 
was adjusted to pH 4.8 with 1 N HCl, Magnetic stirring, which can 
fracture the gel beads, was avoided. Over a period of five minutes, 1,3 
mmoles (a 2.6-fold excess) of EDAC, a water-soluble carbodiimide, in a 
volume of 1.5 ml,were added with stirring. The pH was adjusted to 4.8 
and checked periodically to maintain that value, The coupling reaction 
thus begun was allowed to proceed 20 hours at room temperature (23°C) 
with no stirring. Subsequently, the gel was packed in an appropriate 
column and washed thoroughly with more than 20 column volumes of the 
buffer to be used in subsequent experiments, This wash was monitored 
using a scintillation counter and when radioactivity had dropped to 
background levels, all of the excess, i.e., unreacted aspartate was 
considered to have been removed. 
A 10 to 20-µl sample of the gel was taken and counted in Bray's 
solution with a scintillation counter. Based upon the gel capacity for 
coupling of 8 to 10 µmoles of amino groups per ml of packed gel and upon 
14 the known amount of C-aspartate added to the gel, the extent of the 
reaction was calculated. Data indicated that at least 2% of the total 
aspartate available was coupled to the gel. This represents ten µmoles 
of L~aspartate bound, which meant that 10 to 12% of the available amino 
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groups in 10 ml of the Af f inose gel were covalently bound to a carboxyl 
group of L-aspartate. 
As to which carboxyl group is linked, no absolute conclusion can 
be made. Both groups may be bound in some proportion, At pH 4.5, the 
Zwitterion of the amino group and the a-carboxyl does exist, since the 
a-carboxyl would not be protonated and the amino group would be pro-
tonated. This internal salt may sufficiently involve the a-carboxyl 
such that it is unavailable and thus most of the coupling reaction takes 
place at the S-carboxyl. Since it is not known which protein, A or B, 
actually binds aspartate or the functional groups involved in that 
binding, the significance for the success of this affinity column of 
which carboxyl is coupled to the gel cannot be evaluated. Figure 7 
depicts the coupling reaction carried out. 
Preparation of Amino-Linked Aspartate 
Affinity Gel 
It was also decided to prepare an affinity column with L-aspartate 
as the ligand in which both carboxyl groups were free and the peptide 
bond was made through the amino group. For this purpose, Affinose 202, a 
succinylaminoalkyl agarose, which has a carboxyl terminal group, was 
employed. To insure coupling with the amino group, the procedures out-
lined by Cuatrecasas and Parikh (184) were followed. This method 
involves the initial formation of the N-hydroxysuccinimide (NHS) ester 
of the terminal carboxyl group, which in turn is quite reactive and 
specific for the amino group of amino acids. 
Affinose 202 was washed as before (as with the amino~terminal 
agarose) and then washed extensively (300 ml) with p-dioxane, since the 
NHS-ester formation must be carried .out in a non-aqueous mediumo The 
10-ml packed volume of gel was added to 20 ml dioxane and 3 mmoles of 
N-hydroxysuccinimide were stirred in as a solid. Again, magnetic 
stirring was avoided. Then 3 mmoles of dicyclohexylcarbodiimide were 
stirred in as the coupling agent. The mixture was stirred gently for 
70 minutes at room temperature (23°C) using an Omni-mixer with a micro 
attachment. set at low rpm. The agarose was afterwards washed over a 
Buchner funnel with six to eight reaction mixture volumes of dioxane 
(6-8 x 30 ml) for 10 minutes, three to four volumes of methanol over 
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five minutes while stirring the gel, and three more volumes of dioxane. 
The activated gel was air-dried for one to two minutes with suction. 
This NHS-ester of the carboxyl-terminal agarose was then imme-
diately used in the coupling reaction with L-aspartate, No carbodiimide 
coupling agent was required, since the NHS-ester is highly reactive 
toward amino groups, Using the ratio of 5 ml of solution per gram (ml) 
of gel, the 10-ml dried gel cake was mixed into 50 ml of 0.05 M KP04 , pH 
7.5, containing 5 mmoles of L-aspartate. The solution was adjusted to 
pH 7.5 after addition of the aspartate and before addition of the gel. 
14 Also, 0.5 µCi of U- C-L-aspartate (160 mCi/mmole) was added to monitor 
the degree of coupling. This mixture was kept at 0 to 4°c before gel 
addition. Then, for five hours, with stirring as described above, the 
coupling reaction was allowed to proceed at 0 to 4°c. Reaction termina-
tion and complete reaction of all ester groups was carried out by addi-
tion of 50 mmoles of glycine and continued stirring at room temperature 
for three hours. The gel was washed extensively with 0.05 M KP04 , pH 
7.5, to remove excess reactants and reaction by-productso 
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14 It was not realized at the time of the addition of the U- C-L-
aspartate that much more labeled aspartate would be needed for monitor-
ing the reaction than that which was added. This is because of the 
much larger amount of unlabeled aspartate used in this reaction in com-
parison to the Affinose 102 coupling reaction, 14 Thus, the C-aspartate 
was diluted such that, theoretically, if the gel were completely coupled 
with aspartate at all available sites, only two to three times back-
ground counts would be observed in counting 20 µl of the gel. Actual 
counts of this volume of gel after reaction were no higher than back-
ground levels. No validation, then, of the existence of amino-coupled 
L-aspartate in the gel or the extent of coupling was made, since this 
method of monitoring the reaction failed and other methods were not 
attempted. The high reactivity of the NHS-ester and the demonstrated 
reliability of the coupling method (184) suggest that at least partial 
linking of the carboxyl groups of the gel did occur, Figure 7 shows the 
ester formation and coupling reactions, 
Preparation of Carboxyl-Linked QA Affinity Gel 
The product of the enzymatic action of tbe A and B proteins, 
quinolinic acid, was found to inhibit the reaction when added in excess, 
Thus, carboxyl-linked QA affinity gel was prepared from QA and Affinose 
102. Five ml (packed volume) of the w-aminoalkyl agarose was washed as 
before and added to 0.5 mmoles (a 10-fold excess) of quinolinic acid and 
3.5 ml of deionized water. The pH of the mixture was adjusted to 4.8 
with KOH with hand mixing. Then 1,3 mmoles of EDAC in 1,5 ml water was 
mixed in over a period of six minutes and the pH was brought back to 
4.8, The final reaction volume of 10.3 ml was allowed to stand 20 hours 
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at 23°c with no mixing. Afterwards, the gel was washed extensively with 
the equilibrating buffer to be used in the experiments. 
The spectrophotometric method of Failla and Santi (185) was 
employed to ascertain the extent of binding of QA to the gel that was 
achieved. Samples of unreacted and reacted gel were prepared as 4% 
suspensions (0.2 ml packed gel for 5 ml) in 50% acetic acid. Two sus-
pensions of uncoupled gel and one of coupled gel were heated at so0 c in 
a water bath for four hours. The re~ulting clear solutions of solubil-
ized agarose were cooled and their pH was adjusted to neutrality without 
visible precipitation. Then 0.2 µmoles of QA (as a 2 mM solution) was 
added to one of the samples with uncoupled gel. Spectra of each solu-
tion were made by scanning the ultraviolet region from 320 to 200 
nmeters using a Varian Model 635 spectrophotometer. A standard 40 µM QA 
solution showed the known absorbance maximum at 268 nm for QA. Compar-
ing scans of the coupled gel, uncoupled gel, and uncoupled gel contain-
ing 40 µM QA, it was calculated that the difference of 0.15 absorbance 
units at 268 nm in the coupled and uncoupled gel without QA was repre-
sentative of a QA concentration of approximately 40 µM QA in the coupled 
gel. The spectrum of the uncoupled gel with added QA was very similar 
to that of the coupled gel, both in overall shape and in amplitude at 
268 nm. Thus, if 5 ml of a solution containing 0.2 ml of gel had 40 µM 
or 0.04 µmoles per ml QA, then 0.2 ml of coupled gel contained 0.2 
µmoles of QA. The entire 5 ml of gel would contain 5 µmoles of bound QA, 
then, which represents 10 to 12% coupling, based upon the 10 to 12 
µmoles-per-ml capacity of the agarose gel. This amount of coupling is 
quite reasonable and the method seems to be very sensitive and relatively 
fast. It was fortuitous that the amount of added QA in the uncoupled 
gel turned out to be very near the amount of QA actually bound to the 
gel. Figure 8 shows the coupling reaction. 
Other Methods 
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Scintillation counting was done by adding 2 ml of the 10-ml Dowex 
50 fraction (0. 01 NHCl) from assays to. 10 ml of Bray's solution in glass 
scintillation vials. Bray's solution contained 100 ml of methanol, 20 
ml of ethylene glycol, 60 grams of naphthalene, 4 grams of 2,5-
diphenyloxazole (PPO), 2 grams of l,4-bis[2-(5-phenyloxazolyl)}-benzene 
(POPOP), and p-dioxane to make one liter. Counting was done on a 
Packard Tri-Carb Liquid Scintillation Spectrometer, Model 3320. Quench 
correction by channels ratio and determination of counting efficiency 
were carried out using Nuclear Chicago quenched standards, a prepared 
quenched standard set with Bray's solution, and known methods for cal-
culations (186), Counting efficiencies normally were 71 to 75%. 
A Beckman DB Spectrophotomer was used to monitor protein from 
column effluents at 280 nm and to check QA recovery from Dowex columns 
at 268 nm, A Varian Techtron Model 635 Spectrophotometer and an A-25 
recorder were employed for making scans in the UV region. 
Protein determinations were made with the Biuret, Lowry, or 280/260 
ratio methods (179) depending upon the type of experiment conducted. 
Routine purification utilized the 280/260 ratio method and the Biuret 
and Lowry methods were used in sonication and crude extract assay exper-
iments. In each case, standard curves were prepared from 10 mg-per-ml 
solutions of bovine serum albumin. Absorbance was checked with the 
Beckman Spectrophotometer in all methods, Determination of cell density 
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in growing cultures was made at 420 nm with a Coleman Jr. Spectrophotom-
eter, Model 6D. 
Concentration methods utilized a Bio-Rad Beaker Ultrafilter b-Hfu-1 
hollow fiber device and Amicon Ultrafiltration cells Models 50 and 202. 
The latter type of equipment was used primarily and both UM-10 and UM-
20E membranes were useful. 
Thin layer chromatography for checking the radiochemical purity of 
14 the U- -C-L-aspartate was accomplished with Eastman #6064 Cellulose 
160-micron chromatogram sheets. After spotting 0.002, 0.02, and 0.2 µCi 
14 
of the C-aspartate, sheets were developed six hours in n-butanol-
acetic acid-water, 25:4:10, and dried. Sheets were then placed under 
GAF X-ray film for 12 hours and purity was checked after development of 
the film. 
Chemicals 
14 The U- C-L-aspartic acid (160 mCi/mmole) utilized in these studies 
was obtained from New England Nuclear and ICN Isotope and Nuclear 
Division. Quinolinic acid, FAD, DHAP, iodoacetamide, aldolase, 
protamine sulfate, pyridoxamine-5 1 -phosphate•HCl, pyridoxal-5'-phosphate, 
the pyridine nucleotides, and L-aspartate and its derivatives were all 
purchased from the Sigma Chemical Company. The Calbiochem Company was 
the source of Bicine, FDP, pCMB, and Aquacide. PPO and POPOP were 
obtained from the Packard Instrument Company, Inc. Polyethylene glycol 
was bought from Matheson, Coleman, and Bell and N-ethyl-maleimide was 
obtained from Eastman Organic Chemicals, DCC was purchased from K and 
K Laboratories, Inc., and EDAC from the Ott Chemical Company. All other 
chemicals were obtained from major supply houses. 
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Chromatography Materials 
Dowex l-X8 chloride form, 200-400 mesh, and Dowex AG 50-X8 hydro-
gen form, 200-400 mesh, were purchased from Bio-Rad Laboratories. Also, 
Bio-Rad was the source of Bio-Gel P-150 and P-300, Agarose Sm and 15m, 
DEAE-cellulose, and Affinose 102, 202, and 501, Sephadex G-100 and 
G-200, DEAE-Sephadex A-50, carboxymethyl-cellulose, carboxymethyl-
Sephadex, and chromatographic columns were purchased from Pharmacia Fine 
Chemicals. Hydroxyapatite was bought from the Clarkson Chemical Company 
and Celite 545 was bought from Fisher Scientific Company. NAD-Agarose, 
or AGNAD, was obtained from P-L Biochemicals, Inc. 
CHAPTER IV 
RESULTS AND DISCUSSION 
Purification of the B Protein 
Many techniques and methods of protein fractionation were utilized 
in this study to effect purification of the B protein from the PA-2-18 
strain. Methods which resulted in the highest recovery of total activ-
ity with a corresponding decrease in total protein (i.e., removal of 
unwanted protein) were incorporated into the purification scheme. 
Simple trial and error and modification of techniques resulted in the 
final purification scheme that is shown in Table V. 
Protamine Sulfate Fractionation 
Removal of nucleic acids was accomplished by addition of protamine 
sulfate to the crude extract. A 2% (20 mg/ml) suspension was prepared 
by adding 550 mg protamine sulfate to 27;4 ml 0.05 M KP04 , pH 7.5, using 
the ratio of 2 mg protamine sulfate to every 10 mg crude extract protein 
(187). The suspension was added dropwise with mixing to 415 ml crude 
extract kept at 0 to 4°c. After the addition was complete and the 
mixture had been stirred another 30 minutes, it was centrifuged 15 
minutes at 8,000 x g. The pellet was discarded and 443 ml of super-
natant were ready for further purification. In all purification steps, 
0.5 or 1-ml samples were removed and stored at -15°c for assay and 
protein determination. 
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Step 
Crude Extract 
Protamine Sulfate Supernatant 
0 to 50% Sodium Citrate Pellet 
Sephadex G-200 (Pooled 
Fractions) 
DEAE-Sephadex (Pooled 
Fractions) 
Hydroxyapatite (Pooled 
Fractions) 
TABLE V 
PURIFICATION OF THE B PROTEIN OF THE QUINOLINATE 
SYNTHETASE SYSTEM IN E. COLI 
Total Total Total Specific 
Volume Protein Activity Activitl _3 (ml) (mg) (units) (units/mg)X 0 
416 111659 12242 1.05 
443 5039 15514 3.08 
23 837.2 10803 12.9 
650 335.0 15470 47.6 
502 55.2 10542 191 
156 8.3 2900 361 
Enrichment 
(-fold) 
1 
2.9 
12.3 
45.3 
182 
344 
Recovery 
(%) 
100% 
127 
88 
126 
86 
24 
V1 
00 
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Frequently, the total activity recovered in the protamine sulfate 
supernatant was greater than the assayed activity in the crude extract, 
This enhancement may be due to the removal of inhibiting substances by 
precipitation with the protamine sulfate or it may occur as a result of 
the action of proteinases in the crude extract that destroy B protein 
activity during storage at -15°c before assay. 
Routinely, this step resulted in recovery of total activity of over 
90% and a one to three-fold increase in specific activity over that of 
the crude extract. Its use, therefore, was quite satisfactory as a 
purification step. 
Sodium Citrate Fractionation 
Fractionation based upon solubility was achieved with sodium 
citrate addition to the protamine sulfate supernatant. A saturated 
solution of sodium citrate was prepared at room temperature (23°C) and 
adjusted to pH 7.0 with saturated citric acid. Then an equal volume 
(443 ml) of this solution was added dropwise to the 443 ml of protamine 
sulfate supernatant which was stirring at 0 to 4°c. After completion 
of this addition and further mixing for 20 minutes, the suspension was 
centrifuged 15 minutes at 8,000 x g. The supernatant was discarded and 
the protein pellet was redissolved in 11 to 12 ml 0.005 M KP04 , pH 7.5, 
with a final volume of 23 ml. Twenty-two ml of this fraction were 
utilized for further purification and 0.5 ml was frozen for assay. 
Dialysis was usually necessary for the redissolved pellet in order 
to remove sodium citrate, but in this case the gel filtration used in 
the subsequent step effectively separated the protein from the salt. 
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When dialysis was done, the redissolved pellet was sealed in 25 mm 
dialysis tubing (boiled three times in 1 mM EDTA) and stirred overnight 
against 3 liters of 0.005 M KP04 , pH 7.5. 
Recovery from sodium citrate fractionation was regularly above 50% 
and protein was reduced to one-sixth of the original amount. Assay of 
the supernatant after dialysis showed less than 5% of the total activity 
from the supernatant was present in that fraction. Sodium citrate was 
found to inhibit the QA synthesis assay and reduce the total amount of 
activity in preparations. Dialysis, however, may contribute signifi-
cantly to this loss of activity, since the B protein is somewhat 
unstable at 4°c. Length of time of exposure of the protein to sodium 
citrate was kept at a minimum in any case. 
Gel Filtration 
A rough separation according to molecular weight and geometry was 
carried out with Sephadex G-200. A 4.5 x 88-cm column which was packed 
at 4°c with 1400 ml of swelled, degassed G-200 was equilibrated with 2 
liters of 0.005 M KP04 , pH 7.5. Then 22 ml of the 0 to 50% saturation 
sodium citrate fraction was mixed with 1 ml of saturated sucrose solu-
tion and layered under the buffer on top of the gel bed. Elution was 
effected by washing the column with 0.005 M KP04 buffer, pH 7.5, using 
a 25-cm head and collecting 9-ml fractions at 4°c. Flow rate of the 
column was about 37 ml per hour and the column was eluted 40 hours, 
Previous determinations of the behavior of the B protein on G-200 
allowed pooling of fractions containing the B protein without first 
assaying the effluent. Fractions 68 to 140 were thus pooled, making 
the pooled G-200 eluate 650 ml in volume. Void volume of the column was 
approximately 410 ml. An elution profile using a smaller column is 
shown in Figure 9. 
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Use of gel filtration as a later purification step involving much 
less protein could have been done with much better fractionation of 
proteins, Also, a smaller column size such as 3 x 64 cm gives better 
resolution. The difficulty of using a smaller column with less protein 
is the tendency of the B protein to lose activity in dilute solution, 
Thus, more protein was required for the applied sample which neces-
sitated a large column. As the purification table indicates, a three-
to four~fold enrichment was obtained with good recovery. 
Anion Exchange Chromatography 
Efficient fractionation of protein was obtained using DEAE-Sephadex. 
A 4 x 13-cm column of DEAE-Sephadex was packed at 4°c and equilibrated 
with 700 ml of 0.005 M KP04 , pH 7.5. Then 647 ml of the pooled G-200 
effluent was passed through the column and the absorbance of the eff lu-
ent was monitored at 280 nm. Monitoring indicated all of the protein 
was bound to the charged groups of the DEAE-Sephadex. The column was 
washed at 4°c with 0.20 M KCl in 0.005 M KPo4 , pH 7.5. After 600 ml, 
protein had dropped to below 0.05 absorbance units at 280 nm in the 
effluent. This wash was discarded and the column was eluted with 375 ml 
of 0.25 M KCl, 0.005 M KPo4 buffer, pH 7.5, after which the protein 
absorbance was again reduced to 0.05 absorbance units. This effluent 
was a fairly dilute protein solution, so 25 and 50-ml portions of 
glycerol, a stabilizing agent, were added as the 375 ml effluent was 
collected. The solution was continuously stirred at 4°c during collec-
tion and the final volume was 504 ml, containing 25% glycerol, 
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A 3-ml sample containing 45 mg of protein the 0 to 50% 
saturation sodium citrate fraction was.applied to the 
3 x 64-cm ~olumn and eluted at 4°c with 0.005 M KP04, 
pH 7.5, collecting 4.5-ml fractions, using a 22-cm 
head. 
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Figure 9. Elution Profile of the B Protein on S~phadex 
G-200 
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Anion exchange gave a clean separation of activity, with almost 
no activity being found in the 0.20 M KCl wash. Utilizing the short, 
wide column, fast stepwise elution can be carried out in 8 to 10 hours. 
Again, a three to four-fold enrichment with good recovery is obtained. 
Hydroxyapatite Chromatography 
Further purification beyond DEAE-Sephadex involved very low protein 
levels as compared to initial steps. Thus, 25% glycerol was used to 
stabilize the B protein by adding it to all buffers. At 4°C, however, 
flow rates of 25% glycerol solutions are quite low, so adsorption 
chromatography using hydroxyapatite was done at room temperature. A 1,9 
x 30-cm column was packed with hydroxyapatite and equilibrated with 500 
ml 0.005 M KP04, pH 7.5, and then 200 ml 0,01 M KP04 , pH 7.5, Both 
equilibrating solutions contained 25% glycerol, Then 500 ml of the 0.25 
M KC! DEAE-Sephadex effluent were passed through the column, and all the 
protein was bound to the hydroxyapatite. The B protein activity was 
subsequently eluted with 0.01 M KPo4, pH 7.5, in 25% glycerol by collect-
ing 9.8-ml fractions. The protein peak as monitored by absorbance at 
280 nm was pooled and resulted in 78 ml of protein solution. 
Although about two-thirds of the total activity of the previous 
fraction from DEAE-Sephadex was lost, sufficient protein was removed so 
that nearly a two-fold increase in specific activity resulted. The 0.25 
M KC! in the protein solution added to the column might have influenced 
protein binding to the hydroxyapatite. Also, glycerol could have had an 
effect on adsorption, but under the conditions used, no adverse effects 
upon adsorption occurred. Sequential use of DEAE-Sephadex and 
hydroxyapatite steps was convenient, as it eliminated the need for an 
intermediate concentration step. 
Evaluation of Purification in the QA 
Synthetase System 
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One aspect of purification of the proteins of the QA synthetase 
system is the low level of protein at which the activities exist, Since 
little QA is needed, enzymes are either not synthesized at high levels 
or they are strongly inhibited. Whatever the case, very small amounts 
of protein are available for such purifications. This often neces-
sitates enrichment values of over 1000-fold before a pure protein can be 
obtained. 
Another difficulty is the apparent instability of the protein. 
Many purification steps beyond the DEAE-Sephadex step failed because of 
denaturation. Glycerol was finally found to reduce the rate of this 
denaturation (as discussed later). Hydroxyapatite columns with this 
stabilizing agent were found to work well in spite of their operation 
at room temperature and dilution of protein solutions below 1 mg/ml, 
Addition of glycerol to buffers for running gel filtrat:lon columns does 
not allow good resolution or flow rate, but a system in which glycerol 
would be mixed with the effluent of the gel column as it is being eluted 
might be worked out. 
Finally, the characteristics of the assay system for quinolinic 
acid biosynthesis made immediate evaluation of purification steps impos-
sible, Minimum time required to complete an assay was.24 hours. If a 
column needed to be moni.tored for activity elution or a decision as to 
procedure needed to be made as an experiment was conducted, only 
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previous information about the behavior of the protein could be used. 
Thus, the overall procedure of selection of purification steps was 
greatly slowed as compared to systems in which a direct spectrophotome-
tric assaysuch as NADH formation can be used. The necessity of the 
presence of two proteins in the assay complicated the evaluation of the 
effect of various reagents employed in purification procedures upon the 
B protein. For example, sodium citrate and potassium chloride are known 
to reduce QA synthesis. However, it is not known upon which protein, A 
or B, or both,that this effect occurso It may be that use of these 
reagents involves a very satisfactory purification step, but appears to 
give low recovery according to the QA assay. 
Progress was made in purification to the point of over 340-fold 
enrichment of specific activity with approximately one-fourth of the 
enzyme activity being recovered from the crude extract, as shown in 
Table V. With modification of present techniques and introduction of 
new ones, it is felt that further purification can be obtained, No 
estimate was made of how pure the B protein is at the 340-fold stage, 
Affinity Chromatography with NAD-Agarose 
Agarose-hexane-NAD (AGNAD) was available commercially from P-L 
Biochemicals, Inc., and was ready to use after washing with deionized 
water. The structure of AGNAD is shown in Figure 8, Ten ml of the 
washed gel was packed in a 0.7 x 32-cm column that had been coated with 
dichlorodimethylsilane (2%) to reduce wall effects. Equilibration was 
carried out at 23°c by washing the gel with 100 ml of 0.05 M KP04 in 
25% glycerol. 
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Thirty-eight ml of a pooled hydroxyapatite 0.01 M KP04 , pH 7.5, 
effluent was concentrated to 6.5 ml with an Amicon 50-ml Ultrafiltration 
cell. Concentration was done at 4°C with a UM-20E membrane with 18 
pounds of nitrogen for four hours. Then 1.5 ml of this concentrated 
hydroxyapatite fraction was applied to the prepared AGNAD column. 
Elution was carried out with the equilibrating buff er at 23°c for about 
24 hours. Two-ml fractions were collected and stored at -150C as soon 
as possible to insure retention of as much B protein activity as pos-
sible. When 120 fractions, or 22 to 24 column volumes had been col-
lected, tubes were thawed, monitored for protein, and assayed with a 
fresh 40 to 60% saturation anunonium sulfate A protein preparation, 
Figure 10 shows the protein and activity profiles of the effluent. 
As shown, the AGNAD does sufficiently retard the movement of the 
B protein through the column such that it elutes much later than the 
bulk of the protein applied to the column. The protein levels in the 
area of the activity peak appear to be quite low, also. Fractions 70 
to 100, at the top of the activity peak, were pooled and then concen-
trated from 60 ml to 5.8 ml by ultrafiltration. Protein determination 
and assay of.these preparations and those of previous purification steps 
indicated only a 65-fold enrichment in the specific activity of the 
concentrated AGNAD fraction over that of the crude extract. Total 
protein, however, was about 0.5 mg in the concentrated fraction from the 
affinity gel, which was only 0.008% of the original protein of the crude 
extract. Thus, very large decreases in the total activity of the B 
protein present occurred, down to 0.5% of the original activity in the 
crude extract. 
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A 1.5-ml volume of the B protein from a pooled, 
concentrated hydroxyapatite column effluent. 
The column was eluted with 0.05 M KP04 , pH 
7.5, in 25% glycerol, collecting 2-ml 
fractions. 
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Figure 10. Elution of the B Protein from NAD-
Agarose 
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Several possible reasons exist for the low specific activity of 
the AGNAD fraction. Most likely, denaturation of the B protein during 
elution of the AGNAD column occurred both from temperature and high 
dilution effects. It is possible that glycerol could not compensate for 
these conditions. A contributing factor may be inaccurate protein 
determination. The method of Lowry, !!, al. (179) was used and should be 
able to distinguish protein concentrations as low as 50 µg per ml. 
Protein determinations of the AGNAD fractions containing the activity 
were not consistent and showed similar results for the pooled and con-
centrated (10-fold) fractions. The glycerol or the phosphate may have 
interfered with the protein determination, If the protein concentration 
is actually 0.1 mg per ml, as found for the pooled AGNAD fraction, then 
much of the B protein present is in denatured form, 
The significance of this type of separation is, of course, the 
possibility of purification of the B protein to homogenicity. This type 
of elution from AGNAD was repeated many times on one-ml gel columns to 
achieve better separation and recovery. No set of conditions was found, 
however, better than the one discussed. The length of the ten-ml column 
allowed much better resolution and separation of protein and activity 
peaks than that for the one-ml columns. If denaturation problems can be 
overcome, it is felt .that the desired purification can be realized. 
+ The binding of .the B protein to AGNAD suggests that NAD is an 
effector of some type of the B protein activity. Unless the binding is 
in the adenine portion of NAD+ (which is the portion to which the 
Agarose sidearm is thought to be bound) as an analog of FAD, the affin-
ity of the B protein for NAD+ seems only to be explainable by feedback 
inhibition. Inhibition studies discussed below appear to support this 
hypothesis. 
Other Purification Methods 
Nucleic Acid Removal 
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Three reagents were tested for their efficiency of nucleic acid 
removal with corresponding retention of B protein activity. Streptomycin 
sulfate (10%), protamine sulfate (2% suspension), and MnC12 (1 M) were 
used according to known methods (27, 187, 188). Each addition was made 
in a dropwise manner with stirring to 10-ml volumes of crude extract 
(16 mg protein per ml) at 4°c. After 30 minutes mixing, the suspensions 
were centrifuged and the supernatants were assayed, Streptomycin 
sulfate and MnC12 did not cleanly fractionate the activity or give good 
recovery. 
Protamine sulfate, however, appeared to precipitate much protein 
and nucleic acids without destroying activity or removing the B protein 
from solution. Experiments were conducted to determine the optimum 
amount of protamine sulfate to add as the 2% suspension. To separate 
20-ml volumes of crude extract, increasing volumes of the protamine sul-
fate suspension were added to obtain concentrations of 2, 3, 4, and 5 mg 
of protamine sulfate per 10 mg of protein. Assay of the resulting 
supernatants indicated that 2 mg protamine sulfate per 10 mg protein was 
the best concentration for maximum recovery, which was often above 90%, 
Fractionation by Solubility 
Initially, Suzuki, et al. (65) found that the B protein precipitated 
in the 0 to 40% saturation fraction using ammonium sulfate, Such 
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fractionation usually resulted in a five to seven-fold increase in 
specific activity and 25 to 50% recovery, based on the crude extract. 
Then sodium citrate was tested as a substitute for ammonium sulfate and 
found to give better fractionation of the protamine sulfate supernatant 
when added to 50% saturation. Routinely, the 0 to 50% saturation sodium 
citrate fraction yielded 10 to 15-fold.enrichment and 50 to 75% 
recovery. 
Reverse gradient solubilization (189) was attempted to perhaps 
further fractionate the 0 to 50% sodium citrate pellet. The pellet was 
suspended in 50% saturated sodium citrate and mixed with the top layers 
of a Celite 545 column equilibrated with 50% saturated sodium citrate, 
pH 7.0. The Celite acted as a solid support upon which continual 
solubilization and precipitation of protein could occur as the percent 
of sodium citrate in the eluant decreased. A reverse gradient such as 
50% to 20% was applied, separating the 0 to 50% sodium citrate pellet 
into two large protein peaks. Activity appeared to be located in one of 
the peaks, but difficulty was encountered when it was discovered that 
high sodium citrate completely inhibited the QA synthesis assay, 
Dialysis was not a solution, since dilution of protein caused large 
amounts of denaturation. Also, attempts to scale up this type of 
chromatography were not successful in duplicating the separation of 
peaks obtained with smaller Celite columns. If modified properly, 
this method might work, but it appeared that the greatest retention of 
the B protein activity accompanied the shortest exposure time to high 
salt concentrations. 
Acetone fractionation was tested by adding acetone dropwise at 
-15°C to the PS supernatant. Successive additions resulting in O to 
33%, 33 to 50%, and 50 to 75% acetone were made. Each solution was 
mixed well and centrifuged and the redissolved pellets were assayed. 
Although some activity was recovered in the 50 to 75% fraction, no . 
increase in specific activity was observed. 
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Another technique used for precipitation of proteins from solution 
is polyethylene glycol fractionation (190). Polyethylene glycol with a 
molecular weight range from 6000 to 7500 daltons was added as a 50% 
solution to separate volumes of protamine sulfate supernatant to yield 
5, 10, 15, 20 and 25% solutions of polyethylene glycol. After mixing 
and centrifugation, supernatants were assayed for B protein activity. 
No clear fractionation was obtained and the protein seemed to distribute 
itself between supernatants and pellets, with gradual precipitation up 
to 25% polyethylene glycol. Also, it was observed that polyethylene 
glycol inhibited QA synthesis and interfered with protein determina-
tions at 280 and 260 nm. 
Heat Treatment 
The B protein was found to be heat-labile (Suzuki, unpublished 
data), so heat treatment was carried out in the presence of possible 
stabilizing agents. Crude extracts were treated for 5, 10, and 15 
minutes at 55°C in the presence of 5 mM L-aspartate or 1 mM riboflavin. 
Treated mixtures were cooled, centrifuged, and put on dialysis as 
resuspended pellets and supernatants to remove the aspartate and ribo-
flavin. Assays revealed that no it).creases in specific activity had 
occurred and that recovery was well below 30% for most of the fractions. 
In addition, heat treatment with agents known to stabilize B 
activity (see below) was done. Dilut~d 0 to 50% sodium citrate fraction 
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solutions that were 50% glycerol or 50% ethylene glycol were heated at 
five minutes at 50°c. A soluti.on with 2 mM mercaptoethanol was also 
heated. Ethylene glycol and mercaptoethanol solutions lost almost all 
their activity. Very little protein was precipitated in the 50% glycerol 
solution and most of the activity was retained. No feasible purifica-
tion step was suggested by these experiments. 
Acid Treatment 
The B protein was known to be stable at neutral pH, so attempts 
were made to incorporate acid treatment as a purification method. 
Aliquots of the protamine sulfate supernatant fraction were dialyzed 16 
to 18 hours at 4°C against potassium phosphate, sodium citrate, or 
sodium acetate buffers at pH 4.5, 5.0, 5.5, and 6,0, Pellets showed a 
three to seven-fold increase in specific activity but many would not 
redissolve in buffer even when neutralized to pH 7.0, Recovery of 
activity was below 25% for the pellets, also. Neutralized supernatants 
retained more than 50% of the total activity in the starting fraction, 
but showed little or no increase in specific activity. Direct addition 
of 7% acetic acid resulted in even poorer retention of activity. A 
gradual denaturation of the B protein seemed to be occurring as the pH 
was lowered. 
A combination of sodium citrate and acid fractionation was 
accomplished by addition of 1 M citric acid to the protamine sulfate 
supernatant until pH 6.0 was reached. Then the solution was brought to 
40% saturation by the addition of solid sodium citrate and mixed well, 
No improvement in purification was observed. Direct addition of 0.1 N 
HCl to the 0 to 50% sodium citrate fraction until the pH of 6.0 was 
reached yielded similar results. 
Thus, an apparently irreversible denaturation of the B protein 
occurs at pH of 6.0 and below. This gradual loss of activity with 
decreasing pH makes such treatment impractical as a purification step. 
Gel Adsorption 
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Calcium triphosphate and Alumina Cy gels were checked for their 
ability to adsorb the B protein selectively or not adsorb it .at all. 
Either case would provide a useful tool for the removal of unwanted 
protein. The protamine sulfate supernatant fraction was treated without 
dilution and with 1:10 dilution at gel concentrations from 1 to 25.mg 
dry gel per mg protein. After mixing the protein and the gel and allow-
ing adsorption to occur, the supernatants from centrifugation were 
assayed. Adsorption of activity to both types of gel paralleled the 
adsorption of protein, such that specific activity was not increased. 
Most protein adsorption occurred in the 1 to 5 mg dry gel to mg protein 
range. Elution of gels with 0.20 M KCl released no activity from the 
gel. 
Ion Exchange and Adsorption Chromatography 
Anion exchange chromatography proved to be quite useful in 
purification of the B protein. DEAE-cellulose columns routinely equili-
brated with 0.005 M KP04 , pH 7.5, were eluted stepwise with phosphate 
buffer or KCl solutions after application of the dialyzed 0 to 50% 
sodium citrate fraction. After washing with 0.10 M KP04 , pH 7.5, or 
0.15 M KCl, activity was eluted with 0.20 M KP04 or 0.20 M KCl, 
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respectively. These procedures resulted in a two to three-fold.increase 
in specific activity and a 10 to 15% recovery. 
DEAE-Sephadex A-50, which has a higher capacity for protein than 
DEAE-cellulose, was found to give 3 to 10-fold enrichment in specific 
activity over the sodium citrate fraction applied with an accompanying 
overall recovery of 20 to 30%. Therefore, it was used in place of DEAE-
cellulose. 
Linear gradient elutions on DEAE-Sephadex columns were attempted, 
but high dilution and low flow rates resulted in high activity losses. 
Stabilizing agents were employed, but often the activity levels were too 
low to detect. The faster stepwise elution required 8 to 10 hours and 
was preferred. 
No binding of the protein on the cation exchange media carboxy-
methyl-cellulose or carboxymethyl-Sephadex was observed. These were 
tested at pH 6.5 and 7.5, respectively, and might have bound the protein 
at lower pH, but denaturation would have occurred at those pH valueso 
Hydroxyapatite was first employed using a stepwise elution at 4°c 
after application of a dialyzed 0 to 40% saturation salt fractionation 
preparation. Activity was eluted with 0.05 M KP04 , pH 7.5. When 
glycerol was found to stabilize the B protein, hydroxyapatite columns 
were run at room temperature with 25% glycerol in the buffer. The B 
protein then eluted in 0.01 M KP04 , pH 7.5, with an overall recovery of 
up to 25% and with a two to three-fold increase in specific activity 
over the previous purification step. 
Gel Filtration 
Three major protein peaks were observed on an Agarose 5 m 
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(exclusion limit - 5,000,000 daltons) column, 2.6 x 35 cm. The middle 
peak, with intermediate molecular weights, consistently contained the B 
protein. Agarose 15 m (exclusion limit - 15,000,000 daltons) showed a 
similar elution pattern. High dilution caused overall recovery for such 
steps to drop to less than 5%. The use of 25% glycerol in the eluting 
buff er of the Agarose 5 m column apparently decreased resolution of the 
gel, although recovery was increased to 25 to 30%. Broader peaks with 
more protein resulted in only a doubling of specific activity. 
Other gels used were P-60, P-150, P-300, and G-100. Of these, only 
P-300 gave good separation of the activity from the bulk of the protein 
in the effluent. However, P-300 flow rates were extremely slow. G-200 
gave the best elution results, as previously discussed and as shown in 
Figure 9. 
Concentration 
In order to employ gel filtration steps after such steps as DEAE-
Sephadex, concentration of pooled fractions 10 to 100-fold became 
essential. A hollow fiber device was employed but bubbling and frothing 
and other denaturation caused a 97% loss in activity. Sodium citrate 
precipitation with 60% saturation yielded over 50% of the activity of the 
dilute solution. However,dialysis was required with this method, requir-
ing time and reducing activity. Lyophilization of pooled fractions 
required 16 to 20 hours for 10-fold concentration with 35 to 45% recov-
ery. Aquacide III, a flake polyethylene glycol (molecular weight ~ 
20,000), removed up to 20 to 30 ml of water per hour from dilute solu-
tions in dialysis tubing. It was discovered, however, that the 
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polyethylene glycol passed through the dialysis membrane and caused 
high "protein" levels in the solution concentrated, as well as inhibit"':' 
ing the assay for activity. 
Ultrafiltration was the most successful method of concentration 
utilized. The UM-ZOE (exclusion limit - 15-25,000 daltons) membrane was 
used with 18 to 20 pounds nitrogen, with usually over 50% recovery. The 
important advantage of this technique is that it can be used at 4°c or 
23°c, .with or without 25% glycerol. At 4°c without glycerol, 380 ml can 
be concentrated to 5.5 ml in 11 hours. Slower rates are observed with 
25% glycerol. 
Affinity Chromatography 
The binding of a specific protein by a specific ligand attached to 
a solid support has great potential for the purification of proteins. 
Considering the low levels of prot~ins responsible for QA synthesis and 
their ease of denaturation, the technique is especially attractive for 
use.in isolating the proteins of the QA synthetase system. Thus, 
several types of affinity columns were prepared (Chapter III) or pur-
chased and employed in attempt$ to purify the B and A proteins. 
Carboxyl-Linked Aspartate Affinity 
Chromatography 
The first Affinose.102-Aspartate columns used had 10 ml of gel and 
were run at 4°c with 0.005 M K.Po4 , pH 7.5. Application of the B protein 
preparations resulted in complete loss of activity and binding of all 
protein applied, some of which was eluted by 0.20 M and 0.40 M KCl con-
centrations. Elution of the .B protein with 0.05 M and 0.10 M L-aspartate 
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also failed to recover any activity from the column. Identical results 
were obtained with KCl elution of the A protein. 
Then a one-ml column was packed and equilibrated with 0.05 M KPo4, 
pH 7.5, to reduce the apparent non-specific binding which was occurring. 
The buffer also had 25% glycerol to stabilize the protein. Experiments 
conducted with this column indicated that the B protein did not bind 
specifically or non-specifically to the aspartate column in 0.05 M KPo4 , 
pH 7.5, since the column wash immediately showed a protein peak and an 
activity peak. Failure of the B protein to bind the carboxyl-linked 
affinity gel suggested that one or both of the carboxyl groups are 
required for aspartate to bind the B protein, or that the B protein does 
not bind aspartate even as a substrate. 
Amino-Linked Aspartate Affinity Chromatography 
The Affinose 202-aspartate column was also initially used in a 
10-ml volume at 4°c with 0.005 M KP04, pH 7.5. Non-specific binding was 
shown to occur by the addition of bovine serum albumin (BSA) to a column 
of uncoupled Affinose 202. The BSA was bound to the column and subse-
quently was eluted with KCl. Since many free carboxyl groups exist in 
the gel after the coupling reaction (from aspartate, glycine, and the 
sidearm), ion exchange may be occurring with these groups. 
Therefore, a one-ml column of the gel was packed and equilibrated 
with 0.05 M KP04 , pH 7.5, to eliminate non-specific binding. It was 
assumed that failure to observe elution of the B protein was caused by 
very tight binding of the protein to the gel, Elution was attempted 
with 0.05 M L-aspartate and 0.05 M N-acetyl-L-aspartate and 0.5 M KCl. 
The KCl fraction contained small but definite activity. 
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The next experiment was carried out at 23°C with 25% glycerol, 
using a stepwise elution of KCl with increments of 0.20 M KC! from 0 to 
0.80 M. Activity was found in the 0.20 M KCl fraction, Further exper-
iments with the gel at room temperature failed to show any binding at 
all of .the B protein to the gel. Finally, an .experiment in which 0.02 
mM FAD was present in .the eluting buffer as a possible aid to binding 
also failed to show any attachment of the B protein to the gel. No· 
binding was observed when the A protein was applied to the column at 
23°c with 0.05 M K.Po4 , pH 7.5 and 25% glycerol. 
0 Therefore, what at first appeared to be specific binding at 4 C was 
demonstrated to be non-specific binding at room temperature. Eventually, 
perhaps with saturation of some kind of the charged groups on the gel, 
the binding ceased completely. Glycerol had been established, at least, 
as a stabilizer that would enable recovery of some activity to monitor 
the affinity gel. It seems probable that at least one of the proteins, 
A or B, must bind aspartate. All possibilities for that binding, how-
ever, were not explored, and aspartate binding to A or B may be only a 
matter of ionic strength, steric orientation, sidearm length, or other 
variables. Also, it is possible that both carboxyl groups and the amino 
group are required for binding o~.aspartate to one of the proteins, in 
which case an affinity column prepared from unmodified aspartate cannot 
be successful. Inhibition of QA synthesis by N-acetyl-L-aspartate 
suggests that a substrate can bind with only the two carboxyl groups, 
with the amino group blocked to cause inhibition. This must be sub-
stantiated by much more detailed study, however. 
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Carboxyl-Linked QA Affinity Chromatography 
The Affinose 102-QA was equilibrated with 0.05 M KP04 , pH 7.5, with 
25% glycerol. Both A and B proteins were applied to the column.in 
separate experiments and elution was carried out with KCl and QA. 
Neither protein was bound to the column, but passed through with the 
protein peak. 
This result is not surprising, since QA is probably bound to the 
proteins that synthesize it through one or both carboxyl groups. Even 
if only one carboxyl group is required for binding, it is likely that 
steric hindrance by the sidearm and the gel itself would block the pro-
tein from access to that side of the QA molecule. 
Based on these ideas, it was thought.that if 6-aminoquinolinic acid 
(6-AQA) could be linked to Affinose 102, the sidearm and gel attachment 
to the other side of the molecule than the carboxyl groups would leave 
the carboxyl groups free to bind the protein or proteins. However, 
6-AQA was not available commercially, so preparation of the compound was 
attempted, based on similar preparations of 2, 3-pyrazinedicarboxylic 
acid (191). The permanganate oxidation of 2-aminoquinoline was done by 
the addition of 6.6 mmoles of KMno4 in 75 ml of water to 1.12 mmoles of 
2-aminoquinoline in 25 ml of water. The addition was made over a period 
of 3.5 hours and the mixture was kept at 90°c with mechanical stirring 
and refluxing. Subsequent isolation and analysis of the reaction 
product(s) gave unclear information about the identity of the product. 
Various methods, including thin layer chromatography, could not conclu-
sively identify the product as 6-AQA, so the preparation was not 
continued. Therefore, this avenue of affinity chromatography remains 
open if 6-AQA synthesis can be carried out successfully. 
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Organomercurial Agarose.Affinity Chromatography 
Affinose 501 (pCMB-Agarose) was purchased commercially and was used 
-5 . 
based on the observation that 10 M pCMB inhibited QA synthesis 
(Suzuki, unpublished observations), This suggests that free sulfhydryl 
groups are present somewhere in the protein and are somehow necessary 
for activity. A one-ml column was packed and washed with 0.05 M KP04 , 
0 pH 7.5 at 4 C. After application of the B protein preparation, elution 
with buffer, mercaptoethanol, and KCl was carried out, Fractionation 
of proteins was achieved, but no activity was detected in any effluents. 
The column was run again at room temperature in buffer with 25% glycerol, 
using cysteine as the eluting ligand. Mercaptoethanol may inhibit QA 
synthesis, whereas cysteine does not at the concentrations used. Again, 
however, no activity was detected in the effluent fractions. It appears 
that denaturation was occurring when the B protein was binding to the 
pCMB-Agarose, If the protein did not bind, it would have passed through 
the column and retained some activity, at least, when assayed, since 25% 
glycerol was used. The presence of a sulfhydryl group might explain the 
binding that seems to occur on the pCMB-Agarose as well as the effect of 
various sulfydryl reagents and possibly the instability of the B protein 
in dilute solutions. 
Linearity of Assay and Protein Stabilization 
Dependence of QA Synthesis on the Amount of 
B Protein 
Since almost all assays were conducted in the presence of excess 
A protein for quantitatively determining B protein activity, it was 
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important to insure that the levels of the B protein were actually 
rate-limiting to QA synthesis. A 0 to 50% sodium citrate fraction from 
PA-2-18 was assayed in dilutions. from 1:10 to 1:200 using a fresh 40 to 
60% ammonium sulfate preparation of SB-16. The protein concentration 
of the 0 to 50% sodium citrate fraction was determined to be 7.35 mg 
per ml by 280 and 260 nm ratios. The units of QA synthesis activity 
were calculated for each assay tube and averaged for duplicate samples. 
Units were plotted against µg of B protein in the assay tubes. 
As shown in Figure 11, linear dependence of QA synthesis on the 
amount of B protein was achieved. Presumably, then, by conducting 
assays with B protein amounts from 1 to 10 units per assay tube and with 
an excess of A protein activity, accurate quantitative evaluation of B 
protein activity may be made. 
Glycerol Stabilization of the B Protein 
The problem of denaturation of the B protein in dilute solutions 
and at room temperature made the use of a stabilizing agent necessary 
for further purification steps and for running columns at 23°c. 
Glycerol was found to do this job when added to the buffer solutions. 
Experiments were conducted to determine the optimum percent glycerol 
necessary to stabilize the B protein activity at -15°, 4°, and 23°c. 
Solutions of 0 to 50% sodium citrate fraction from PA-2-18 were 
prepared with glycerol and without glycerol to a final dilution of 1:20. 
Glycerol-containing solutions were O, 10, 15, 20, and 25% glycerol. 
Corresponding solutions without glycerol substituted 0.05 M KP04 buffer, 
pH 7.5. Small volumes of each type of solution were stored in tubes 
ready to assay at each temperature. After 24 hours, tubes were assayed 
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with excess A protein. Remaining activity was calculated as a percent-
age of the 0 to 50% sodium citrate fraction diluted just before assay. 
Table VI shows the effect of temperature and the presence of 
glycerol on remaining enzyme activity. Glycerol stabilized and even 
enhanced B protein activity when assayed after storage at -15°c and 4°c. 
At room temperature, however, 20 or 25% glycerol was required before 
complete retention of activity was achieved. Activity remaining in 
samples with buffer varied considerably, but the effect of room tempera-
ture was again quite pronounced. Such information was quite useful in 
choosing temperatures and glycerol concentrations for particular 
columns. More dilution than used here, of course, would have much 
greater effect on the stability of the a protein, and thus increa•ing 
the amounts of glycerol that would nave to be uaed. 
Glycerql S~abilhati5m of the A Protein 
A greater problem in loss of activity was found in the A protein 
fractions for both storage of the 40 to 60% ammonium sulfate for assay 
and for purification of the A protein itself, Most immediate was the 
need to maintain high activity in fractions stored for use in the B 
protein assay. Thus, experiments were conducted over two weeka in order 
to allow the decay of A activity with and without 33% glycerol. The 
buffer and glycerol-containing solutions were assayed on days l, 2, 3, 
6, 8, 10, and 13, using an excess of B protein. Remaining activity was 
expressed as a percent of the initial units existing on day one in the 
33% glycerol fraction. 
Table VII shows that glycerol again enhanced QA synthesis and 
protected the A activity for nearly two weeks. Rapid decay of activity 
84 
TABLE VI 
STABILIZATION OF THE B PROTEIN WITH GLYCEROL8 
No Dilution (O to 50% Sodium 
Citrate Fraction at -15% 
diluted just before assay) 
With Glycerol 
10% 
15% 
20% 
25% 
With Buffer 
10% 
15% 
20% 
25% 
a See text for experimental details. 
Percent of ActLvity Remaining 
(% of Units of Undiluted B Protein) 
27.9 
76.5 
80.4 
115 
110 
23.6 
11.8 
22.1 
22.0 
Temperature 
4°c 
92.2 
110 
111 
116 
119 
91. 9 
61.0 
78.8 
88.9 
-15°C 
104 
103 
105 
104 
98.6 
102 
84.6 
89.0 
b Actual activity of preparation used as 100% activity remaining was 905 
units/ml B fraction. 
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was noted after three days in the fraction with buffer. If this 
fraction is not used within three days after preparation, then glycerol 
should be included with the solution when it is frozen. The convenience 
of high activity A protein is thus afforded and assays could be carried 
out.for one week with the same preparation. 
TABLE VII 
STABILIZATION OF THE A PROTEIN WITH GLYCEROLa 
Percent of Activity Remaining 
(% of Units of 33% Glycerol on Day l~ 
Addition to A Protein 
Time of Storage (Days) Buffer, 33% Glycerol, 33% 
1 99.6 loob 
2 81.3 96, 6 
3 83.8 107 
6 52.2 97.8 
8 54.6 96.1 
10 53.2 106 
13 18.4 87.3 
aSee text for experimental details. 
b Actual activity of preparation used as 100% activity remaining was 8,5 
units/ml A fraction. 
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The Effect of Cofactors and Inhibitors 
on QA Synthesis 
Pyridine Nucleotides 
The first enzyme in a biosynthetic pathway is often subject to 
control mechanisms such as feedback inhibition. The results of Chandler 
and Gholson (64) suggested the possibility of feedback inhibition of the 
+ QA synthetase system in ~· coli by NAD . Experiments, therefore, were 
conducted to determine the effect of pyridine nucleotides upon the QA 
synthetase system using a more highly purified preparation of B protein. 
Assays were conducted using a fresh 40 to 60% ammonium sulfate 
preparation from SB-16 and a concentrated hydroxyapatite effluent from 
PA-2-18. The B protein preparation had a specific activity of 167 units 
per mg and was purified 100-fold from the crude extract. Assays were 
done as usual with the exception of the addition of 0.1 ml of the 
reagent tested, making final assay volumes 0.6 ml. Pyridine nucleotide 
stock solutions at concentrations of 20 mM were prepared in deionized 
water and adjusted to neutral pH. Stock solutions were diluted appro-
priately for obtaining the desired concentrations in the assay tubes, 
Table VIII shows the QA synthesis and inhibition data. Marked 
inhibition of QA synthetase activity occurred with the addition of NAD+ 
or NADH. NADH showed slightly less inhibition than NAD+ at all con-
centrations used. + Much less inhibition by NADP and NADPH occurred and 
the action appeared to be much less dependent on concentration of these 
compounds. NMN was unique in its enhancement of QA synthesis by as much 
as 5%. 
TABLE VIII 
THE EFFECT OF PYRIDINE NUCLEOTIDES ON QA SYNTHESISa 
QA Synthesis Activity Percent Inhibition 
(Units/mlB Protein Fraction (of Control 
Final Concentration in Assa 
Addition to Assay 3.33 mM 1.0 mM .33 mM 3.33 mM 1.0 mM 
H2o 513 513 513 0 0 
NAD+ 22.6 237 437 95.6 53.9 
NADH 41.3 217 414 92.0 57.8 
NADP+ 368 366 436 28.3 28.6 
NADPH 393 408 487 23.5 20.5 
aSee text for experimental details. 
.33 mM 
0 
10.9 
19.2 
15.0 
5.0 
CX> 
"-.I 
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It appears that NAD+ is an effective inhibitor of QA synthesis, as. 
previously reported in a crude system (64). These experiments showed 
+ 100% inhibition of QA synthesis with 3.33 mM NAD (final concentratiQn), 
which is very similar to present results. It is difficult to say if 
NAD+ is an inhibitor of QA synthesis in .Y!Y.g_, at cellular NAD+ levels, 
+ but the 50% inhibition by 1 mM NAD suggests the possibility, since 
cellular levels are in the 0.1 to 1.0 mM range (104). 
+ In an attempt to localize the site of NAD inhibition, the reac-
tions for NAD inhibition were repeated, using limiting amounts of the A 
+ protein. In this experiment, NAD was added to make the final concen-
tration 1 mM. Excess B protein was added and 2; 10, and 40-fold reduc-
tions in the A protein achieved rate-limiting conditions for the A 
+ protein. Table IX shows that less inhibition by NAD occurred under 
+ these conditions. A possible interpretation of results is that NAD 
acts on the B protein and not the A protein. 
The existence of a complex between A and B that is responsible for 
catalysis is a possibility that cannot be disregarded. The failure of 
the demonstration of a free intermediate may be evidence for this. 
Inhibition effects observed would then be results of inhibiting the 
complex and not individual proteins, thus invalidating at~empts to 
+ determine which protein binds NAD by excess and rate-limiting levels of 
one protein. 
Pyridoxal-Phosphate and Pyridoxamine-Phosphate 
Assays were conducted to check the effect of these coenzymes at 
concentrations 3.33, .33, and .033 mM. Stock solutions of 20 mM were 
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prepared in the same way as those for the pyridine nucleotides. Assays 
were also the same• 
TABLE IX 
NAD+ INHIBITION IN CONDITIONS OF EXCESS B PROTEIN 
Addition to Assay 
Excess B Protein 
A Protein Added (mg) 
.1 
.4 
2.0 
Excess A Protein 
B Protein Added (mg) 
.017 
Total QA Synthesis 
(Units per Assay) 
H20 NAD+ 
1.32 1.02 
5.08 4.64 
27.6 21.3 
24.2 12.4 
Percent Inhibition 
(of Control) 
H 0 NAD+ 2 
0 22.7 
0 8.7 
0 22.8 
0 51. 2 
Table X indicates a greater inhibition by pyridoxal-phosphate as 
compared to pyridoxamine-phosphate. A previous report (64) indicated 
equal inhibition by these, but one is only 10% of the other in these 
results. It is quite possible that a non-specific chemical reaction of 
the aldehyde group of pyridoxal-phosphate is occurring that results in a 
decrease in QA synthesis. This would explain the difference observed 
with pyridoxamine-phosphate, which has no aldehyde group. Multivalent 
TABLE X 
THE EFFECT OF NMN, PYRIDOXAL-PHOSPHATE, AND PYRIDOXAMINE-PHOSPHATE ON QA SYNTHESISa 
QA Synthesis Activity I UnitsLml B Fraction2 
Final Concentration in Assa 
Addition to Assay 
H2o 
NMN 
Pyridoxal-5'-P 
Pyridoxamine-5'-P 
.HCl 
3.33 mM 
513 
533.5 
163.5 
476.3 
aSee text for experimental details. 
.33 mM .033 mM 3.33 mM 
513 513 0 
537.4 526.3 -4.0 
383.9 422.3 68.1 
385.1 445.7 7.2 
Percent Inhibition 
(of Control 
.33 mM 
0 
-4.8 
25.2 
24.9 
.033 mM 
0 
-2.6 
17.7 
13.1 
\0 
0 
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inhibition of QA synthesis by pyridine-containing cofactors might also 
be considered as a possible mechanism. 
Aspartic Acid and Related Compounds 
In the same assay system, the effect of several derivatives of L-
aspartate was tested. The apparent inhibition by 5 mM L-aspartate is 
due to isotope dilution in the assay, since the addition of 2.5 µmoles 
of unlabeled L-aspartate represented a 10-fold increase in the aspartate 
levels in the assay. Thus, an inhibition of 90% would be expected for 
QA synthesis if isotope dilution was occurring, and 82.7% was observed, 
as shown in Table XI. 
TABLE XI 
THE EFFECT OF L-ASPARTATE AND RELATED COMPOUNDS 
ON QA SYNTHESISa 
QA Synthesis Activity Percent Inhibition 
Units/ml B Fraction of Control 
Final Concentration in Assa 
Addition to Assay 5 mM .5 mM 5 mM .5 mM 
H2o 461.9 461. 9 0 0 
L-Aspart~te 79.8 313.0 82.7 32.2 
D-Aspartate 415.4 433.9 10.l 6.1 
N-Acetyl-L- 404.9 449.1 12.3 2.8 
Aspartate 
DL~Aspartate 348.9 385.9 24.5 16.5 
Dimethyl Ester 
a See text for experimental details. 
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Of the others shown in Table XI, the dimethyl ester showed the 
greatest affect on QA synthesis. It is possible that these inhibitory 
effects by the aspartate analogs are the result of their conversion to 
L-aspartate and subsequent isotope dilution in the assay. However, all 
the enzymes for such conversions are likely not present in the protein 
preparations.used. At 5 mM, the inhibition by the dimethyl ester may 
indicate the relative importanqe of the carboxyl groups in the binding 
involved in QA biosynthesis. Previous experiments resulted in over 50% 
inhibition of the assay by 20 mM N-acetyl-L-aspartate, and these results 
are consistent with that amount of inhibition. Again, interpretation of 
the action of particular inhibitors on the significance of particular 
groups of the substrate in binding is difficult in this system. 
Sulfhydryl Reagents 
Three types of sulfhydryl reagents were tested in this assay 
system, as shown in Table.XII. These preliminary results suggest that 
-4 -5 10 or 10 M concentrations of N-ethylmaleimide and pCMB would also 
give significant inhibition, since.10 mM and 1 mM are both highly inhib-
itory to QA synthesis. The iodoacetamide was pre-incubated about five 
0 
minutes at 23 C with the B protein, resulting in a large amount of 
inhibition. These results, the behavior on pCMB-Agarose, and the 
!ability of the B protein in dilute solutions.all suggest the involve-
ment of sulfhydryl groups in the synthesis of quinolinic acid. 
Other Sources of Enzyme Activity 
E. coli K-12 Strains 
Other mutants of E. coli K-12 were checked for A and B protein 
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activity. Strains PA-2-18 (nad !_), AT-11-23 (nad A), SB-16 (!!!£.!), 
W-3899 (!!!£. ].) , E-126 (!!!£. .£), SB-99 (E!!!. .£), W-4516 (nad .£), and AT-
13-3 (nad .£) were grown in 100-ml cultures at 37°c with the appropriate 
growth factors (see Table IV), After .12 hours, cultures were harvested 
by centrifugation .at 8000 x g for 15 minutes. Crude extracts were pre-
pared as described previously and assayed for the A protein, the B 
protein, and then both activities, using PA and SB extracts. Protein 
was determined by absorbance at 280 and 260 nm. Table XIII shows the 
comparison of the specific activities of the mutants. 
TP,.BLE XII 
THE EFFECT OF SULFHYDRYL REAGENTS ON QA SYNTHESISa 
QA Synthesis Acitivity 
Units/ml B Fraction 
Percent Inhibition 
of Control 
Final Concentration in Assa 
Addition to Assay 10 mM 1 mM 10 mM 1 mM 
H2o 461.9 461.9 0 0 
Iodoacetamide 37.2 200 92.0 56.7 
p-Chloromercuri- 3.5 35.9 99.2 92.2 
benzoate 
N-Ethylmaleimide 5.8 75.0 98.7 83.8 
a See text for experimental details. 
Qualitatively, these results would be expected from genetic 
knowledge of these strains. The differences in the amounts of these 
TABLE XIII 
A AND B PROTEIN ACTIVITIES IN NADA, NADl!., AND NADf., STRAINS OF E. COLia 
Specific Activity I Percent of Activity Units/mg) x lo-3 (Based uoon PA-2-18 and SB-16 
Enz e Activit 
Mutant A Protein B Protein A and B Protein A Protein B Protein 
nad A 
PA-2-18 48.2 964 44.9 5.0 100 
AT-11-23 29.6 952 22.7 I 2.3 73.3 
nad B 
SB-16 1200 31. 7 16.7 100 2.7 
W-3899 718 31.8 23.8 53.4 2.4 
n~ 
E-126 1150 566 664 101.5 50.3 
SB-99 600 382 404 51.9 33.2 
W-4516 920 672 748 67.6 49.7 
AT-13-3 79.7 532 19.0 5.8 39.1 
aSee text for experimental details. \0 +:-
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activities may or may not have significance, It is interesting to note 
that all the activities for the A proteins in nad ]! mutants, for 
example, are well within an order of magnitude of each other. This is 
true for activities present in the natl ! and natl £.mutants as well. The 
strain AT-13-3 is genetically classed as a nad .£mutant, but has very 
low A protein activity, similar to nad ! mutant, as observed in these 
studies. 
E-126 Strain 
.§_ • .£211. E-126 was used as a source for the partial purification of 
the A and B proteins. Cultures were grown and harvested in an identical 
manner as the PA-2-18 strain, except for growth supplements. Sonication 
and crude extract preparation was also done as before. Simultaneous 
purification of both activities from the strain was not possible, since 
the purification steps for one protein would inactivate or exclude the 
other protein. Table XIV indicates the B protein purification from 
E-126. No significant differences appear to exist in the behavior of 
this activity. The A protein purification, also shown in Table XIV, 
appears to be quite similar .to other A preparations. Both E-126 prep-
arations had somewhat lower activities than those observed for PA-2-18 
and SB-16, respectively. 
Mung Bean Plant 
Crude extracts of the mung bean plant Phaseolus vulgaris were 
checked for their ability to synthesize QA. Plants were grown from seed 
for eight days in a controlled humidity growth chamber, after which the 
TABLE XIV 
PURIFICATION OF THE A AND B PROTEINS FROM E. COLI STRAIN E-126 
Total Total Total Specific 
Volume Protein Activity Activity _3 Enrichment Recovery 
Step (ml) (mg) (units) (units/mg)xlO (-fold) (%) 
B Protein 
Crude Extract 194 4656 16199 3.5 1 100 
Protamine Sulfate 212 3286 14522 4.4 1.3 89.6 
Supernatant 
0 to 50% Sodium 7.1 234 5495 23.5 6.7 33.9 
Citrate Pellet 
DEAE-Cellulose 173 52 3689 71.0 20.4 22.8 
(Pooled Fractions) 
A Protein 
Crude Extract 95 2260 1000 0.44 1 100 
Heat Treatment 93 2840 804 0.28 0.6 80.4 
Supernatant. 
40 to 60% Ammonium 18.4 258 405 1.57 3.6 40.5 
Sulfate·Pellet 
\0 
O'\ 
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first set of leaves besides the cotyledons had formed. Entire seedlings 
were washed, dried, cut into large pieces, and frozen in a large mortar 
with liquid nitrogen. The pieces were ground to a fine powder with 
continued addition of liquid nitrogen and then to a pulpy slurry by 
addition of 50 ml of 0.05 M KP04 , pH 7.5. The well-mixed slurry was 
sonicated as described previously for small volumes of bacterial crude 
extracts and centrifuged 15 minutes at 20,000 x g. The decanted super-
natant was assayed for both A and B protein activities according to 
methods described previously. 
The assays were conducted with FDP or DHAP. Aldolase was added to 
the assay tubes when FDP was used as substrate in the event the native 
enzyme was not active or present in the extracts. Results were negative 
for all substrates and all assays. Thus, it appears that in this assay 
system no QA is synthesized. Both A and B protein activities appear to 
be lacking. No known reports on NAD+ or NA biosynthesis in this 
organism have been published, but it is assumed that de !!:£YQ_ synthesis 
of QA occurs as in other higher plants, from a three-carbon unit and a 
four-carbon dicarboxylic acid (75). Many possible explanations could be 
14 given for the failure to demonstrate C-aspartate incorporation into 
QA. The substrates may be different or the proteins themselves suf-
ficiently different in structure or action to prevent the substitution 
of a bacterial enzyme for the plant enzyme. Or, if the enzymes are 
present in these extracts, it may be inhibited by another protein or 
14 
effector or completing enzymes rapidly utilize the C-aspartate present. 
The enzymes may have been denatured by freezing, sonication, or even 
assay incubation; whatever the case, much more work will be needed to 
clarify QA synthesis in this organism. 
CHAPTER V 
CONCLUSIONS 
The elucidation of the enzymatic activities and of the inter-
mediates of the pathways of biosynthesis of vitamins appears to present 
a special problem in that only very low levels of the vitamins are 
required. + Particularly, in NAD biosynthesis, the enzymes for bio-
synthesis comprise only a small fraction of the total protein in the .§.. 
coli cell. Much greater purification from crude extracts is necessary, 
therefore, to obtain a homogenous.protein in this pathway. 
The purification data presented for the B protein in.this study 
represent the purest preparation of an enzyme activity for QA synthesis 
that has been reported to date. Rearrangement and modification of these 
purification techniques should improve the purification from 340-fold to 
perhaps 500-fold. Many different methods for purification were 
attempted and most of these were eliminated as unsatisfactory tech-
niques. Perhaps purification of the B protein from other strains of !· 
coli.or even other microorganisms may be carried out with the methods 
that were utilized in this study. This would greatly speed elucidation 
of the QA synthesis system in these organi$ms. 
The most promising result for purification, however, is the 
behavior of the B protein on the NAD+ affinity column. Proper modifica-
tion of this type of elution seems to provide a method of obtaining a 
highly purified B protein. A large volume of PA-2-18 crude extract 
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(1 to 2 liters) is required for such a purification. + Since the NAD -
Agarose is less specific for the B protein than,an aspartate affinity 
cqlumn, for example. the .most purified protein preparation from 0th.er 
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me.thods sho.uld. be -applied, to die column. to reduce to a minimum the 
number of proteins that bind NAD+ (dehydrogenases), Perhaps a modifica-
tion of the temperature (to 4°c) or the glycerol concentration is 
necessary. 
The aspartate and QA affinity columns that failed to bind the.B 
protein might do so under differ~nt conditions, but this does not seem 
likely. The functional groups of L-aspartate and QA that were used_to 
couple these ligands to the Affinose gels are probably necessary for 
their binding to the protein. Alternatively, in vivo, these molecules 
may not bind at all to the B protein. If the process of QA synthesis is 
a two-step reaction, then aspartate should bind as a substrate to one 
protein and QA should bind as a product to the other. The existence of 
a complex _between the A and B proteins would further complicate the 
possibilities, since both proteins would then need to be applied .to the 
affinity column to observe binding of the ligand. If the A protein is 
to.be-isolated by affinity chromatography, some of these possibilities 
will need to be investigated in order to prepare the proper affinity 
column to obtain binding. 
All evidence indicates that NAD+ binds the B protein .and effects 
its activity for.in vitro synthesis of QA. This is demonstrated by.the 
+ behavior of the B protein on NAD -Agarose as well as inhibitor studies 
with pyridine nucleotides. + This binding is apparently specific for NAD 
+ or NADH, and suggests a regulatory function for NAD in the quinolinate 
synthetase system. Obvious~y, since NAD+ is the end product of the 
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pathway in a functional sense, at least, this suggests classical feed-
back inhibition is occurring. + Alt~rnatively, NAD may function as an 
FAD analog, suggesting FA.P binds the B protein. Either possibility may 
be true at this point .and only further inhibition stud:l-es with highly 
pur~fied enzyme preparations will distinguish between the two. 
Inhibition by aspartat~ derivatives suggests an apparent specif i-
city for L-aspartate at levels.below 0;5 mM, at least. Partial 
inhibiti.on by both N-acetyl-L-aspartate and the d:l-methyl ester .of 
asparta.te implies that both carboxyl groups and the amino group of L-
aspartate are involved in binding to the protein invo.lved. This appears 
to agree with incorporation data for labeled L~aspartate, in whi~h all 
carbon atoms.and t~e nitrogen atom form part of QA. Stability charac-
teristics and sulfhydryl reagent .. effects indicate that some type of 
sulfhydryl group is important in the A or B protein activities. 
It must be kept .in mind in all t~ese studies, however, that one is 
looking not just at the_B protein as far as synthesis of QA is con-
cerned. This holds true especially for the inhibitor studies, since 
both proteins (and many others) are present in the assay with the co-
factor.or inhibitor. Effects observed on QA synthesis may be a result 
of action upon the A or the B protein or both, or neither protein; in 
which case side reactions involving other enzymes are occurring. The 
effects are on the 0verall system, i.e. , on the assay, and not on the 
specific proteins. In this sense, the assay for QA is a limiting factor 
for characterizing the system further. 
The A and B pr0teins of the system appear to be identical in other 
strains of E. coli. Likely, they are present in all microorganisms that 
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utilize the aspartate-DHAP pathway to make QA. No activity of this kind 
could be demonstrated in the mung bean plant, however. 
These studies and their results, then, have answered a few ques-
tions, but, typical of most research, they have generated many more 
questions and possibilities to explore. A step has been made, though, 
that eventually will enable study of the B protein of the quinolinate 
synthetase system in a pure form and perhaps may culminate in the final 
elucidation of this pathway in .§_. coli. 
A SELECTED BIBLIOGRAPHY 
(1) Huber, C, (1867) "Vorlaufige Notiz Uber Einige Derivate Des 
Nico tins. 11 Justus Liebigs Ann. Chem. , 141, 271. 
-- ---
(2) Huber, C. (1870) 11Vorlaufige Mittheilung. 11 Ber. Deut. Chem. 
Ges • , 3 , 84 9 . 
(3) Funk, C, (1911) 11 0n the Chemical Nature of the Substance Which 
Cures Polyneuritis in Birds Induced by a Diet of Polished 
Rice. 11 l_. Physiol., (London) fl.3, 395. 
(4) Funk, C. (1913) "Studies on Beri-Beri. VII. Chemistry of the 
Vitamine-Fraction From Yeast and Rice-Polishing." J. 
Physiol., (London) ~Q, 173. 
(5) Suzuki, u., Shimamura, T., and Odake, S. (1912) "Uber Oryzamin, 
Ein Bestandteil Der Reiskleie und seine Physiologische 
Bedeutung. 11 Biochem. ~., 4~, 89. 
(6) Goldberger, J., and Tanner, W. F. (1925) "A Study of the 
Pellagra-Preventive Action of Dried Beans, Ca.sein, Dried 
Milk, and Brewers' Yeast, With a Consideration of the 
Essential Preventive Factors Involved." Q. • .§_. Public Health 
Report, {±Q, 54. 
(7) Elvehjem, C. A., Madden, R. J., Strong, F. M., and Woolley, D. W. 
(1937) "Relation of Nicotinic Acid and Nicotinic Acid Amide 
to Canine Black Tongue, 11 .J.. Am. Chem. Soc. , .22, 196 7. 
(8) Spies, T. D., Cooper, C., and Blackenhorn, M.A. (1938) "The Use 
of Nicotinic Acid in the Treatment of Pellagra." .:!.· Am. Med. 
Assoc., !!Q, 622. 
(9) Fouts, P. J., Helmer, 0. M., Lepkovsky, S., and Jukes, T. H. 
(1937) "Treatment of Human Pellagra With Nicotinic Acid. 11 
Proc. Soc. Exptl. Biol. Med., 2z, 405. 
(10) Smith, D. T., Ruffin, J.M., and Smith, S. G. 
Successfully Treated With Nicotinic Acid: 
.:!_.Am. Med. Assoc., 1Q2, 2054. 
(1937) "Pellagra 
A Case Report." 
· (11) Kreh!, W. A., Sarma, P. S., Teply, L. J,, and Elvehjem, C. A. 
(1946) "Factors Affecting the Dietary Niacin and Tryptophane 
Requirement of the Growing Rat." .:!_. Nutro, ~!, 85. 
102 
103 
(12) Harden, A., and Young, W. (1909) "The Hexosephosphate Formed by 
Yeast Juice From Hexose and Phosphate." f!:.2.£.· Roy, Soc., 
(London) Ser. B ~!' 528. 
(13) Albus, H., Schlenk, F., and Von Euler, H. (1935) 11Uber Die Co-
Zymase. 11 Z. Physiol. Chem., 237, L 
- -- ---
(14) Warburg, 0., and Christian, W. (1936) "Pyridin, Der 
Wasserstoffubertragende Bestandteil Von Garungsfermenten 
(Pyridin-Nucleotide). n Biochem. Z., 287, 291. 
- """""'"" 
(15) Warburg, 0., and Christian W. (1931) "Uber Aktivierung Der 
Robisonschen Hexose-Mono-Phosphorsaure in Roten Blutzellen 
und die Gewinnung Aktivierender Fermentlosungen. 11 Biochem. 
~· ' ~~~' 206. 
(16) Warburg, o., and Christian, W. (1934) "Co-Fermentproblem, 11 
Biochem .. ~·, n{±, 112. 
(17) Von Euler, H., Schlenk, F., and Vestrin, R. (1937) 11Adenosin-
Diphosphorsaure Aus Co-Zymase. 11 Naturwissenschaften, g2, 
318. 
(18) Von Euler, H., Karrer, P., and Bocker, Bo 
isierung van Zuckerphosphorsauren und 
Pentose-Phosphorsaure Aus Cozymase. 11 
1060. 
(1936) 11Charakter-
Konstitution der 
Helv. Chim. ~·, 12, 
(19) Schlenk, F. (1937) 11Die Einwirkung van Phosphoroxychlorid auf 
Cozymase. 11 Naturwissenschaften, i2, 668. 
(20) Schlenk, F. (1943) "Nicotinamide Riboside. 11 Arch, Biochem., ,J, 
93. 
(21) Warburg, o., and Christian, W. (1935) "Co-Fermentproblem." 
Biochem. ~.,kl,?, 112 and 446. 
(22) Pullman, M. E., San Pietro, A., and Colowick, S. P. (1954) "On 
the Structure of Reduced Diphosphopyridine Nucleotide," .:L~ 
Biol. ~·, iQ§, 129. 
(23) Loewus, F. A., Vennesland, B., and Harris, D. Lo (1955) "The 
Site of Enzymatic Hydrogen Transfer in Diphosphopyridine 
(24) 
Nucleotide. 11 ;!_. Am. Chem • .§.££.., ZZ, 3391. 
Rafter, G. W., and Colowick, S. P. 
Reduced N-Methylnicotinamide. 11 
(1954) 110n the Structure of 
,:[. Biol. Chem., 2.Q9, 773. 
(25) Florikin, M., and Stotz, E., Ed. (1973) Comprehensive Bio-
chemistry, Vol. 13, 3rd Ed., Enzyme Nomenclature Recommenda-
tions - 1972, Elsevier Publishing Co., Inc., New York. 
104 
(26) Olivera, B. M., and Lehman, I. R. (1967) "Linkage of Poly-
nucleotides Through Phosphodiester Bonds by an Enzyme From 
Escherichia coli. 11 Proc • Natl. Acad. Sci. U • .§.. , 2Z, 1426. 
(27) Zimmerman, S. B., Little, J. W., Oshinsky, C. K., and Gellert, Mo 
(1967) "Enzymatic Joining of DNA Strands: A Novel Reaction 
of Diphosphopyridine Nucleotide. 11 f..!.Q.£.• ~· ~· Sci. 
u. .§.. , 2Z , 184L 
(28) Olivera, B, M., and Lehman, I. R. (1967) "Diphosphopyridine 
Nucleotide: A Cofactor for the Polynucleotide-Joining 
Enzyme From Escherichia .£Q.!f.. 11 Proc. Natl. Acad o ..§.£.!.. Q. • .§.., 
_2Z, 1700. 
(29) Gellert, M. (1967) 11Formation of Covalent Circles of Lambda DNA 
by .!2_. coli Extracts. 11 Proc. Natl. Acad • ..§.£.!.· U • .§.., .2Z, 148, 
(30) Weiss, B. , and Richardson, C. C. (1967) 11Enzymatic Breakage and 
Joining of Deoxyribonucleic Acid. I. Repair of Single-
Strand Breaks in DNA by an Enzyme System From Escherichia 
Coli Infected with T4 Bacteriophage, 11 Proc. Natl. Acad, Sci. 
Q.. §..., .2Z, 1021. 
(31) Spadari, S., Ciarrocchi, G., and Falaschi, A. (1971) 11Purifica-
tion and Properties of a Polynucleotide Ligase From Human 
Cell Cultures. 11 Eur. .:!_. Bio chem, , ~~, 7 5. 
(32) Kessler, B. (1971) 11Isolation, Characterization and Distribution 
of a DNA Ligase From Higher Plants." Biochim. Biophys. Acta, 
~~2, 496. 
(33) Collier, R. J., and Pappenheimer, A •. M., Jr. (1964) 11 Studies on 
the Mode of Action of Diptheria Toxin. II. Effect of Toxin 
on Amino Acid Incorporation in Cell.,.Free Systems. 11 .:!.· 
Exptl. Med., !~Q, 1019. 
(34) Collier, R. J. (1967) "Effect of Diptheria Toxin on Protein 
Synthesis: Inactivation of One of the Transfer Factors." .:!.· 
Mol. Biol. , ~,2, 83, 
(35) Honjo, T., Nishizuka, Y., Hayaishi, O., and Kato, I. (1968) 
"Diptheria Toxin-Dependent Adenosine Diphosphat~ Ribosylation 
of Aminoacyl Transferase II and Inhibition of .Protein 
Synthesis. 11 !l.· Biol • .illl!.m.·, i~~, 3553. 
(36) Gill, D. M., Pappenheimer, A. M., Jr., Brown, R., and Kurnick, 
J. T. (1969) "Studies on the Mode of Action of Diphtheria 
Toxin. VII. Toxin-Stimulated Hydrolysis of Nicotinamide 
Adenine Dinucleotide in Mammalian Cell Extracts." .:!.· Exptl. 
Med. , t~2, 1. 
(37) Goar, R. S., and Maxwell, E. S. (1970) 11The Diphtheria Toxin-
Dependent Adenosine Diphosphate Ribosylation of Rat Liver 
Aminoacyl Transferase II: General Characteristics and 
Mechanism of the Reaction. 11 :!.· Biol. Chem. , Z~.2, 616. 
105 
(38) Honjo, T., Nishizuka, Y., Kato, I., and Hayaishi, Oo (1971) 
11Adenosine Diphosphate Ribosylation of Aminoacyl Transf erase 
II and Inhibition of Protein Synthesis by Diphtheria Toxin. 11 
.J... Biol. Chem., ,6~.§, 4251. 
(39) Gill, D. M., and Pappenheimer, A. M., Jr. (1971) 
Activity Relationships in Diphtheria Toxin. 11 
_t~§, 1492. 
11 Structure-
:!.· Biol. Chem., 
(40) Collier, R. J., and Kandel, J, (1971) 11Structure and Activity 
of Diphtheria Toxin. I. Thiol-Dependent Dissociation of a 
Fraction of Toxin into Enzymically Active and Inactive 
Fragments. 11 :!.· Biol. Chem., ,6~§, 1496. 
(41) Nishizuka, Y,, and Hayaishi, o. (1963) 11Studies on the Bio-
synthesis of Nicotinamide Adenine Dinucleotide. I. Enzymic 
Synthesis of Niacin Ribonucleotides From 3-Hydroxyanthranilic 
Acid in Mammalian Tissues." :!.· Biol, Chem,, t2~, 3369. 
(42) Hundley, J. M. (1954) "XIII, Requirements and Factors Influenc-
ing Animals and Man 11 in "Niacin11 in The Vitamins, Vol. II, 
W. H. Sebrell, Jr. and R. S. Harris, Ed., Academic Press, 
Inc. , N. Y. , p, 5 7 8. 
(43) Beadle, G. W., Mitchell, H. K., and Nye, J. F. (1947) 
"Kynurenine as an Intermediate in the Formation of Nicotinic 
Acid From Tryptophane by Neurospora. 11 Proc. Natl, Acad. Sci. 
Q.. ~·' 22, 155. 
(44) Birnbaum, D., Boettcher, F., and Samsonova, I, A. (1972) 
"Nicotinic Acid Biosynthesis in Rhodotorula glutinus. 11 z. 
Allg. Mikrobiol., 1t' 365. 
(45) Desaty, D., and Vining, L. c. (1967) "Biosynthesis of Nicotin:i,c 
Acid by Fusarium oxysporum Schlecht. 11 Can. :!.· Biochem., ~2, 
1953. 
(46) Audettte, R. C. S., Purvis, J, L., Worthen, L. R., and Youngken, 
H. W., Jr. (1973) 11Pyridine Nucleotide Biosynthesis in 
Claviceps. 11 fil:.£h. Bio.chem, Biophys. , 12~, 17 3. 
(47) Ahmad, F., and Moat, A. G. (1966) "Nicotinic Acid Biosynthesis 
in Prototrophs and Tryptophan Auxotrophs of Saccharomyces 
cerevisiae," :!.·Biol. Chem., ~~1, 775. 
(48) Lingens, F., and Vpllprecht, P. (1964) "Zur Biosynthese Der 
Nicotinsaure in Streptomyceten, Algen, Phycomyceten and 
Hefe." Z. Physiol. Chemie., 1~2, 640 
106 
(49) Lingens, F., Vollprecht, P., and Gildemeister, v. (1966) "Zur 
Biosynthese Der Nicotinsaure in Xanthomonas- und Pseudo-
monas-Arten, Mycobacterium phlei und Rotalgen," Biochem. ~·, 
J~~' 462. 
(SO) Davis, C,, Henderson, L. M., and Powell, D. (1951) "The Niacin-
Tryptophan Relationship in the Metabolism of Xanthomonas 
Pruni." .:!_. fil:.21· Chem. , !~.2, 543. 
(51) Yanofsky, C. (1954) "The Absence of a Tryptophan-Niacin Rela-
tionship in Escherichia coli and Bacillus subtilis." .:!.· 
Bacterial., §~, 577. 
(52) Volcani, B. E., and Snell, E. E. (1948) "Specificity of the 
Response of Various Assay Organisms to Nicotinic Acid." 
Proc. Soc. Exptl. Biol. Med., §Z, 511. 
(53) Mathes, E., Gross, D., Schutte, H. R., and Mathes, K. (1961) 
"Zur Biosynthese der Nicotinsaure bei Mycobacterium 
t'uberculosis (Stamm BCG)." Naturwissenschaften, ~§, 623. 
(54) del Rio-Estrada, c,, and Patino, H. (1962) "Nicotinic Acid Bio-
synthesis by Mycobacterium tuberculosis, 11 .:!_. Bacterial., 
.§~, 871. 
(55) Isquith, A. J., and Moat; A. G. (1966) "Biosynthesis of NAD and 
Nicotinic Acid by Clostridium butylicum." Biochem. Biophys. 
Res. Commun., 22, 565. 
- . --
(56) Isquith, A. J., and Moat, A.G. (1965) Bacterial. Proc., !2§2, 
74. 
(57) Scott, T. A., and Hussey, H. (1965) "The Biosynthesis of 
Nicotinic Acid in Serratia marcescens. 11 Biochem •.. .:!_., 2§, 
9c. 
(58) Henderson, L. M,, Someroski, J. F., Rao, D.R., Wu, P.H. L., 
Griffith, T., and Byerrum, R. U. (1959) "Lack of a 
Tryptophan-Niacin Relationship in Corn and Tobacco." .:!.· 
Biol. Chem., ~i~, 93. 
(59) Yang, K. S., and Waller, G. R. (1965) "Biosynthesis of the 
Pyridine Ring of Ricinine from Quinolinic Acid Glycerol and 
Aspartic Acid." Phytochem. , ~, 881. 
(60) Ortega, M. V., and Brown, G. M. (1960) "Precursors of Nicotinic 
Acid in Escherichia coli. 11 .:!_. Biol. Chem., ~~,2, 2939. 
(61) Andreoli, A. J., Ikeda, M., Nishizuka, Y., and Hayaishi, O. 
(1963) "Quinolinic Acid: A Precursor to Nicotinamide 
Adenine Dinucleotide in Escherichia coli. 11 Biochem. Biophys. 
Res. Commun.,!~, 92. 
107 
(62) Ogasawara, N., Chandler, J. L. R., Gholson, R. K., Rosser, R. Jo, 
and Andreoli, A. J. (1967) "Biosynthesis of Quinolinic Acid 
in a Cell-Free System." Biochim. Biophys. ~' .!~.!, 199. 
(63) Chandler, J. L. R., Gholson, R. K., and Scott, T. A. (1970) 
'!Studies on the de ~ Biosynthesis of NAD in Escherichia 
~· I. Lal:>elling Patterns from Precursors." Biochim. 
Biophys. Acta, ttt' 523. 
(64) Chandler, J. L. R., and Gholson, R. K. (1972) 11Studies on the 
Biosynthesis of NAD in Escherichia coli. III. Precursors of 
Quinolinic Acid in Vitro. 11 Biochim. Biophys. ~' t§~, 311. 
(65) Suzuki, N., Carlson, J.P., Griffith, G. R., and Gholson, R. K. 
(1973) 11Studies on the de ~ Biosynthesis of NAD in 
Escherichia coli. V. Properties of the Quinolinic Acid 
Synthetase System." Bfochim. Biophys. ~' .2,Q~, 309. 
(66) Gross, D., Schutte, H. R., Hubner, G., and Mothes, K. (1963) 
"The Biosynthesis af Nicotinic Acid by Mycobacterium 
t'uberculosis. 11 Tetrahedran Letters, No. 9, 541. 
(67) Leete, E. (1965) "Biosynthesis of Alkaloids. 11 Science, .!~Z, 
1000. 
(68) Albertson, J. N., Jr., and Moat, A.G. (1965) "Biosynthesis of 
Nicotinic Acid by Mycobacterium \uberculosis. 11 J. Bacterial., 
§.2' 540. 
(69) Feige, A., Gross, D., Zureck, A., and Schutte, H. R. (1970) 
"Beitrage zur Biosynthese von Nicotinsaure und Chinolinsaure 
bei Mycobacteriumbovis Stamm BCG. 11 Arch, Mikrobiol., Z_2, 
80r · . . 
(70) Gross, D., Banditt, P., Zureck, A., and Schutte, H. R. (1968) 
"Chinolinsaure als Zwischenstufe in der Nicotinsaure-
Biosynthese bei Mycobacterium bovis Stamm BCG. 11 ~· 
Naturforsch, t1, 390. 
(71) Konno, K., Oizumi, K., Shimizu, Y., Tamagawa, S., and Oka, S. 
(1966) "Niacin Metabolism in Mycobac.teria; Mechanism of 
Excess Niacin Production by Human Tubercle Bacilli." Am. 
Rev. Resp. Dis. , 2~ , 41. 
(72) Scott, T. A., and Mattey, M. (+968) "The Incorporation of 
Formate into Nicotinic Acid by Clostridium butylicum. 11 
Biochem • .f•, !2Z' 606. 
(73) Scott, T. A., Bellion, E,, and Mattey, M. (1968) "The Synthesis 
of Nicotinic Acid from N-Formyl-L-Aspartate by Extracts of 
Clostridium butylicum. 11 Biochem., .:I.•, 1QZ, 23P. 
108 
(74) Scott, T. A., Bellion, E., and Mattey, Mo (1969) "The Convereion 
of N-Formyl-L~Aspartate into Nicotinic Acid by Extracts of 
Clostridium butylicum. 11 Eur • .:[. Biochem. , J:Q, 318. 
(75) Leete, E. (1969) "Alkaloid Biosynthesis, 11 in Advances.in 
Enzymology, Vol. 32, F. F. Nord, Ed., Interscience; N. Y,, p. 
373. 
(76) Aronoff, S. (1956) "Experiments on the Biogenesis of the 
Pyridine Ring in Higher Plants. 11 Plant Physiol., _2!, 355, 
(77) Leete, E. (1957) "The Biogenesis of the Pyridine Ring of 
Nicotine." Chem. Ind. (London), !.2.2Z, No o 38, 1270. 
(78) Waller, G. R., and Henderson, L. M. (1961) 11Biosynthesis of the 
Pyridine Ring of Ricinine. 11 J. Biol. Chem., iJ.§, ll86. 
(79) Griffith, T., and Byerrum, R. U. (1959) "Biogenesis of Nicotine. 11 
Science, !~2, 1485. 
(80) Leete, E. (1958) "Biogenesis of Anabasine: Preferential 
Incorporation of Acetate into the Pyridine Ring. 11 Chem. Ind. 
(London), !.22§, No. 45, 1477. 
(81) Griffith, T., Hellman, K. P., and Byerrum, R. U. (1960) 
on the Biogenesis of the Ring Systems of Nicotine." 
Chem., ~~2, 800. 
"Studies 
J. BioL 
- --
(82) Waller, G. R., and Henderson, L, M. (1961) "Biosynthesis of the 
Pyridine Ring of Ricinine from Succinate and Other Labeled 
Compounds. 11 Biochem. Biophys. Res. Commun., 2, 5. 
(83) Juby, P. F., and Marion, L. (1961) "The Biogenesis of Ricinine. 11 
Biochem. Biophys. Res. Commun., 2, 461. 
(84) Anwar, R. A., Griffith, T,, and Byerrum, R. U. (1961) "Bio-
synthesis of Ricinine in Ricinus communis L." Federation 
Proc., iQ, 374. 
(85) Yang, K. S., Gholson, R. K., and Waller, G. R. (1965) 11 Studies 
on Nicotine Biosynthesis. 11 J. Am. Chem. Soc., ~z, 4184. 
(86) Griffith, T., and Byerrum, R. U. (1963) 11Biosynthesis of the 
Pyridine Ring of Nicotine from Succinate and Acetate," 
Biochem. Biophys. Res. Comm~n., 1Q, 293. 
(87) Leete, E., and Friedman, A. R. (1964) 11Biosynthesis of the 
Nicotiana Alkaloids. X. The Incorporation of Glycerol-
2-14c into the Pyridine Ring of Anabasine. 11 .:[. Am, Chem. 
Soc. , §.§, 1224. 
(88) Ju by, P. F., and Marion, L. (1963) "The Origin of Carbon Atoms 
2, 3, and 7 of Ricinine." Can, .:!_. ~·, ~J:, ll7. 
109 
(89) Essery, J, M., Juby, P. F., Marion, Lo, and Trumbull, J. (1963) 
11The Origin of Carbon Atoms 4, 5, and 6 of Ricinine," Can. 
l..· Chem.,~!, 1142. 
(90) Johns, S. R., and Marion, L. (1966) "The Role of Aspartic Acid 
in the Bio synthesis of Ricinine," Can. l..· ~·, ~~, 23. 
(91) Jackanicz, T. M., and Byerrum, R. U. (1966) 11 Incorporation of 
Aspartate and Malate into the Pyridine Ring of Nicotine. 11 
l..· Biol. Chem., t~1, 1296, 
(92) Fleeker, J., and Byerrum, R. U. (1967) 11 Incorporation of 
Glyceraldehyde into the Pyridine Ring of Nicotine, 11 J, 
Biol. Chem., t~t' 3042, 
(93) Waller, G. R., and Yang, K. S. (1967) 11The Origin of the 
Nitrogen Atoms of Ricinine Produced by Ricinus communis L. 11 
Phytochem., §, 1637. 
(94) Hadwiger, L. A., Badiei, S. E., Waller, G. R., and Gholson, R. K. 
(1963) 11Quinolinic Acid as a Precursor of Nicotinic Acid 
and its Derivatives in Plants." Biochem. Biophys. Res, 
Commun.,!~, 466. 
(95) Gross, D., Banditt, P., Kurbatow, J. W,, and Schutte, H. R, 
(1968) 11 Zur Biosynthese des Ricinins, 11 f, PflanzenphysioL, 
_2§, 410. 
(96) Frost, G. M., Yang, K. S,, and Waller, G. R. (1967) 11Nicotinamide 
Adenine Dinucleotide as a Precursor of Nicotine in Nicotiana 
r.ustica L, 11 l..· BioL Chem. , t~t, 887. 
(97) Kaplan, N. Q, (1961) "Metabolic Pathways Involving Niacin and 
its Derivatives, n in Metabolic Pathways, Vol. II, D, M. 
Greenberg, Ed. , Academic Press, Inc, , N. Y, , Ch, 22, 
(98) Preiss, J., and Handler, P. (1958) "Biosynthesis of Diphospho-
pyridine Nucleotide. L Identification of Intermediates," 
l..· Biol. Chem. , ~~~, 488. 
(99) Preiss, J., and Handler, P, (1958) "Biosynthesis of Diphospho-
pyridine Nucleotide. II. Enzymatic Aspects." I· Biol. 
Chem., tJJ, 493. 
(100) Gholson, R. K. (1966) "The Pyridine Nucleotide Cycle." Nature, 
~g, 933. 
(101) Joshi, J. G., and Handler, P. (1962) "Purification and 
Properties of Nicotinamidase from Torula cremoris." J. 
Biol. Chem., ~n, 929. 
(102) Sarma, D, S. R., Rajalakshmi, S., and Sarma, P, S. (1961) 
11Deamidation of Nicotinamide and NMN." Biochem, Biophys, 
Res. Commun., §, 389. 
110 
(103) Packman, P. M., and Jakoby, W. B. (1965) 11Quinolinate 
Phosphoribosyltransferase. 11 
1§, 710. 
Biochem. Biophys. Res. Commun., 
(104) lmsande, J. (1961) "Pathway of Diphosphopyridine Nucleotide 
Bio synthesis in Escherichia coli. 11 .:!.· Biol. Chem. , g2§, 
1494. 
(105) Sundaram, T. K. (1967) "Biosynthesis of Nicotinamide-Adenine 
Dinucleotide in Escherichia coli, 11 Biochim. Biophys, Acta, 
.!_2§, 586. 
(106) Spencer, R. L. , and Preiss, J. (196 7) "Biosynthesis of 
Diphosphopyridine Nucleotide: The Purification and the 
Properties of Diphosphopyridine Nucleotide Synthetase from 
Escherichia coli B," .:!.· Biol. Chem,, ~~~, 385, 
(107) Dahmen, W., Webb, B., and Preiss, J. (1967) "The Deamido-
Diphosphopyridine Nucleotide and Diphosphopyridine 
Nucleotide Pyrophosphorylases of Escherichia coli and 
Yeast. 11 Arch, Biochem. Biophys. , J}Q, 440. 
(108) Tritz, G. J. (1970) 'Genetic Analysis of Mutants of!· coli 
Defective in the Biosynthesis of Nicotinamide Adenine 
Dinucleotide.--Ph.D. Dissertation, the University of Texas 
at Houston. 
(109) Andreoli, A. J., Okita, T. W., Bloom, R., and Grover, T, A. 
(1972) "The Pyridine Nucleotide Cycle: Presence of a 
Nicotinamide Mononucleotide-specific Glycohydrolase in 
Escherichia coli. 11 Biochem. Biophys, Res, Commun,, ~2, 264, 
(110) Schwartz, N. M,, Kaplan, N. O., and Frech, M. E. (1956) 
"Significance of 'Heat-Activated' Enzymes." Science, 1~1' 
50. 
(111) Gholson, R. K., Tritz, G. J,, Matney, T, S,, and Andreoli, Ao J, 
(1969) 11Mode of Nicotinamide Adenine Dinucleotide Utiliza-
tion by Escherichia coli." J. BacterioL, 99, 895. 
-- - --
(112) Andreol~.' A. J., Grover, T., Gholson, R. K., and Matney, T. s, 
(1969) "Evidence for a Functional Pyridine Nucleotide Cycle 
in Escherichia coli. 11 Biochim. Biophys. Acta, 1n, 539. 
(113) Lundquist, R., and Olivera, B. M. (1973) 
Metabolism in Escherichia coli. II • 
.:!.· lli£1· Chem., ~~§, 5137. 
'~yridine Nucleotide 
Niacin Starvation." 
(114) McLaren, J., Ngo, D. T. C., and Olivera, B. M. 
Nucleotide Metabolism in Escherichia coli. 
(1973) 
IIL 
synthesis from Alternative Precursors in Vivo." 
Chem,,~~~' 5144. 
"Pyridine 
Bio-
J. Biol. 
- --
111 
(115) Manlapaz-Fernandez, P., and Olivera, B. M. (1973) "Pyridine 
Nucleotide Metabolism in Escherichia coli. IV. Turnover." 
.:!_. Biol. ~· , t~§, 5150. -
(116) Konno, K., Oizumi, J., and Oka, S. (1965) 11Biosynthesis of 
Niacin Ribonucleotide from Quinolinic Acid by Mycobacteria. 11 
Nature, ZQ~, 874. 
(117) Kasarov, L. B., and Moat; A. G. (1972) "Metabolism of 
Nicotinamide Adenine Dinucleotide in Human and Bovine 
Strains of Mycobacterium tuberculosis." .:!_. Bacteriol., !J:Q, 
600. 
(118) Packman, P. M., and Jakoby, W. B. (1965) "Crystalline 
Quinolinate Phosphoribosyltransferase. 11 J. Biol. Chem., 
Z~Q' PC4107. - -- --
(119) Ahmad, F., and Moat, A.G. (1965) 11Nicotinic Acid Biosynthesis 
in Prototrophs and Certain Yeast Auxotrophs. 11 Federation 
Proc. , .6S-, 480. 
(120) Kahn, V., and Blum, J. J. (1968) "Studies of Nicotinic Acid 
Metabolism in Astasia longa. II. Pathway and Regulation 
of Nicotinamide Adenine Dinucleotide Biosynthesis in Cell-
free Preparations. 11 !!_. Biol. Chem. , ,t~,2, 1448. 
(121) Ohtsu, E., Ichiyama, A., Nishizuka, Y., and Hayaishi, Oo (1967) 
"Pathways of Nicotinamide Adenine Dinucleotide Biosynthesis 
in Nicotinic Acid or Nicotinamide Requiring Microorganisms." 
Biochem. Biophys. Res. Commun., t2, 635. 
(122) Yu, C. K., and Dietrich, L. S. (1972) "Purification and 
Properties of Yeast Nicotinamide Adenine Dinucleotide 
Synthetase, 11 .:!_. Biol. ~·, ~~Z, 4 794. 
(123) Sarma, D. S. R., Rajalakshmi, S., and Sarma, P. s. (1964) 
"Studies on the Enzymes Involved in Nicotinamide Adenine 
Dinucleotide Metabolism inAspergillus niger. 11 Biochim. 
Biophys. Acta, §!, 311. 
(124) Tanigawa, Y., Shimoyama, Mo, Dohi, K., and Ueda, I. (1972) 
"Purification and Properties of Nicotinamide Deamidase from 
Flavobacterium peregrinum. 11 .:!_. Biol. ~·, i!tz, 8036, 
(125) Sundaram, T. K., Rajagopalan, K. V., Pichappa, c. V., and Sarma, 
P. S. (1960) "Studies on Pyridine Nucleotide Biosynthesis. 11 
Biochem • .:[o, ZZ, 145. 
(126) Rajagopalan, K. Vo, Sundaram, T. K., and Sarma, P. S. (1960) 
"Metabolism of Nicotinamide and Nicotinic Acid in Corcyra 
cephalonica St. 11 Biochem • .:!·, Z~, 355. 
112 
(127) Sundaram, T. K. Rajagopalan, K. V., and Sarma, P. S. (1958) 
11Metabolism of Nicotinamide and Nicotinic Acid in Neurospora 
crassa, 11 Biochem • .J..., lQ, 196. 
(128) Luchka, E., and Johnson, W. J. (1965) 11 Inhibition of Nicotina-
mide Deamidase Activity in Bacteria and Pigeon Liver. 11 
Federation Proc., ,6~, 480. 
(129) Grossowicz, N., and Halpern, Y. S, (1956) ninhibition of 
Nicotinamidase Activity in Cell-free Extracts of Myco-
bacterium phlei by 3-Acetylpyridine.n Biochim. Biophys. 
Acta, t9, 576. 
(130) Halpern, Y. S., and Grossowicz, N. (1957) 11Hydrolysis of Amides 
by Extracts from Mycobacteria. 11 Biochem • .J..., §.2, 716. 
(131) Shimoyama, M., Tanigawa, Y., Ito, T., Murashima, R., Ueda, I., 
and Tomoda, T. (1971) 11Nicotinamide Deamidation of Micro-
organisms in Rat Stomach. 11 .J... Bacterial., J:.Q§, 191. 
(132) Hughes, D. E., and Williamson, D, H. (1952) "The Synthesis of 
Cozymase from Nicotinic Acid and its Derivatives by Lacto-
bacillus arabinosus 17-5." Biochem. :I_,, .2t' 330. 
(133) Joshi, J. G., and Handler, P. (1960) "Biosynthesis of 
Trigonelline." .J... fil:tl. ~·, .?.2.2, 298L 
(134) Hughes, D. E., and Williamson, D. H. (1953) "The Deamidation of 
Nicotinamide by Bacteria." Biochem, :I_., 22, 851. 
(135) Imsande, J. (1964) "A Comparative Study of the Regulation of 
Pyridine Nucleotide Formation." Biochim. Biophys, Acta, 
§t, 445. 
(136) Gholson, R. L, and Kori, J. (1964) "Enzyme Repression in the 
Regulation of Nicotinamide Adenine Dinucleotide Biosynthesis 
in Bacillus subtilis," .J... BioL Chem,, ~22, PC2399. 
(137) Ogasawara, N., and Gholson, R. K, (1966) "The Non-identity of 
Yeast Nicotinic Acid Mononucleotide Pyrophosphorylase and 
Nicotinic Acid Mononucleotidase." Biochim. Biophys. Acta, 
!J:§, 422. 
(138) Kosaka, A., Spivey, H. O., and Gholson, R. K. (1971) "Nicotinate 
Phosphoribosyltransferase of Yeast," J. Biol. Chem., i~§, 
3277. 
(139) Dudley, M. A., and Willett, H. P, (1965) "Nicotinamide Adenine 
Dinucleotide Synthesis by Mycobacterium tuberculosis var. 
bovis. 11 Proc. Soc. Exptl. Biol. Med a , 112, 807. 
(140) Friedmann, H. C., and Garstki, C. (1973) 11The Pyridine 
Nucleotide Cycle: Presence of a Nicotinamide Mono-
nucleotide-specific Amidohydrolase in Propionibacterium 
shermanii. 11 Bio chem. Biophys. ~· Commun. , ~Q, 54. 
113 
(141) Fyfe, J. A., and Friedmann, H. C. (1969) "Vitamin Biz Bio-
synthesis: Enz~e Studies on the Formation of the a-Glyco-
sidic Nucleotide Precursor. 11 .::!.· Biol. ~· , .6£1.ft, 1659, 
(142) Imai, T. (1971) 11Studies on Pyridine Nucleotides. I. 
Nicotinamide Mononucleotide Amidohydrolase (NMN Deamidase) 
and a New Pathway for 'Salvage Synthesis' of Nicotinamide-
adenine Dinucleotide. 11 Seikagaku, ~~' 336; Chem, Abstr., 
z2, 105066c. 
(143) Gopinathan, K. P., Sirsi, M,, and Ramakrishnan, T. (1963) 
11Nicotinamide-adenine Nucleotides of Mycobacterium 
tuberculosis H37 Rv." Biochem . .:I•, §Z, 444" 
(144) Mather, L H., and Knight, M. (1972) 11A Heat-Stable 
Nicotinamide-Adenine Dinucleotide Glycohydrolase from 
Pseudomonas putida KBl: Partial Purification and Some 
Properties of the Enzyme and an Inhibitory Protein." 
Biochem • .:I,., 1~2, 141, 
(145) Fehrenbach, F. J. (1969) "Gel-Filtration Behaviour and 
Molecular Weight of NAD-Glycohydrolase (EC 3,2,2.5) from 
Streptococci in Column Chromatography on Sep had ex Gels,'' 
.::!.· Chromatog., ~!' 43. 
(146) Kaplan, N. O., Colowick, S. P., and Nason, A. (1951) 
11Neurospora Diphosphopyridine Nucleotidase," .::!.· BioL 
Chem., 1.n, 473. 
(147) Kern, M., and Natale, R. (1958) "A Diphosphopyridine Nucleo-
tidase and its Protein Inhibitor from Mycobacterium 
butyricum." .::!.· Biol. Chem. , ~.n, 4L 
(148) Green, A. A., and Hughes, W. L. (1955) "Protein Fractionation 
on the Basis of Solubility in Aqueous Solutions of Salts and 
Organic Solvents," in Methods in Enzymology, VoL I, S. P. 
Colowick and N. 0. Kaplan, Ed. , Academic Press, N, Y, , p, 
67. 
(149) Kasarov, L. B., and Moat, A. G. (1973) "Metabolism of the 
Pyridine Nucleotides Involved in Nicotinamide Adenine 
Dinucleotide Biosynthesis by Clostridium butylicum." 
.::!.· Bacteriol., 112, 35. 
(150) Nakajima, Y. , Fukunaga, N, , Sasaki, S, , and Usami, S, (197 3) 
"Purification and Properties of NADP Pyrophosphatase from 
Proteus v·ulgaris. 11 Biochim. Biophys. Acta, ~_2~, 242. 
114 
(151) Fehrenbach, F. J, (1971) "Identity of Streptolysin-0 and NAD-
Glycohydrolase (EC 3.2.2.5). 11 ~· Naturforsch, ,6.6, 1336. 
(152) Fehrenbach, F. J. (1971) "Reinigung und Kristallisation der 
NAD-Glykohydrolase aus C-Streptokokken. 11 Eur• l.· Biochem. , 
.!.§' 94. 
(153) Waller, G. R., Yang, K, S., Gholson, R. K., and Hadwiger, L.A. 
(1966) "The Pyridine Nucleotide Cycle and Its Role in the 
Biosynthesis of Ricinne by Ricinus communis L. 11 l.· BioL 
Chem., ~~1, 4411. 
(154) Hiles, R. A., and Byerrum, R. U, (1969) "The Role of the 
Pyridine Nucleotide Cycle in the Biosynthesis of Ricinine. 11 
Phytochem., .§, 1927. 
(155) Ryrie, L J., and Scott, K. Jo (1969) 
and Nicotinamide as Precursors in 
Nicotinamide-Adenine Dinucleotide 
11~, 679. 
11Nicotinate, Quinolinate 
the Biosynthesis of 
in Barley. 11 Biochem. Io , 
(156) Godavari, H. R., and Waygood, E. R. (1970) "Nicotinamide 
Adenine Dinucleotide Metabolism in Plants. I. Intermediates 
of Biosynthesis in Wheat Leaves and the Effect of 
Benzimidazole. 11 Can. l.· Bot. , ~§, 2267 o 
(157) Lundquist, R., and Olivera, B. M. (1971) 
Metabolism in Escherichia coli. Io 
.::!.· Biol. Chem., t~§, 1107. 
"Pyridine Nucleotide 
Exponential Grewth. 11 
(158) Tritz, G. J., and Chandler, J. L. R. (1973) "Recognition of a 
Gene Involved in the Regulation of Nicotinamide Adenine 
Dinucleotide Biosynthesis. 11 J. Bacterial., .!.!~, 128. 
(159) Imsande, J., and Pardee, A. B. (1962) "Regulation of Pyridine 
Nucleotide Biosynthesis in Escherichia coli.u J. Biol. 
Chem., t2Z' 1305. 
(160) Saxton, R. E., Rocha, V., Rosser, R. J., Andreoli, A. J,, 
Shimoyama, M., Kosaka, A., Chandler, J. L. R., and Gholson, 
R. K. (1968) "A Comparative Study of the Regulation of 
Nicotinamide-Adenine Dinucleotide Biosynthesis. 11 Biochim. 
Biophys. Acta, !2§, 77. 
(161) Witholt, B. (1972) "Method for Isolating Mutants Overproducing 
Nicotinamide Adenine Dinucleotide and Its Precursors. 11 J, 
Bacteriol., .!Q2, 350. 
(162) Smith, L. D., and Gholson, R. K. (1969) "Allosteric Properties 
of Bovine Liver Nicotinate Phosphoribosyltransferase. 11 J. 
Biol. Chem., t~~, 68. 
(163) Imsande, J. (1964) 11A Cross-Linked Control System. I. 
Properties of a Triphosphate-dependent Nicotinic Acid 
Mononucleotide Pyrophosphorylase from Bacillus subtilis." 
Biochim. Biophys. ~' §2, 255. · 
115 
(164) Imsande, J., and Prestidge, L. S. (1964) A Cross-Linked Control 
System. II. Control of Pyridine Nucleotide Formation in 
Vivo. 11 Biochim. Biophys. ~' §_2, 265. 
(165) Gholson, R. K. (1968) "Regulat:i..on of NAD Biosynthesis via the 
Pyridine Nucleotide Cycle. 11 :!.· Vitamin, !~, 114. 
(166) Imsande, J. (1961) "Pathway of Diphosphopyridine Nucleotide 
Biosynthesis in Escherichia .£.Qll.." :!.• .fil.21· Chem., ~~§, 
1494. 
(167) Calbreath, D. F., and Joshi, J. G. (1971) "Inhibition of 
Nicotinamidase by Nicotinamide Adenine Dinucleotide. 11 J, 
Biol. Chem. , t~.§, 4334. 
(168) Pardee, A. B., Benz, E. J., Jr., St. Peter, D. A., Krieger, J. 
N., Meuth, M., and Trieshmann, H. W., Jro (1971) "Hyper-
production and Purification of Nicotinamide Deamidase, A 
Microconstitutive Enzyme of Escherichia coli." .J... Biol. 
Chem.,~~.§, 6792. 
(169) Gopinathan, K. P., Sirsi, M., and Vaidyanathan, C. S. (1964) 
"Nicotinamide-Adenine Dinucleotide Glycohydrolase of 
Mycobacterium tuberculosis H'.37Rv." Biochem. l_., ~!, 277, 
(170) Gopinathan, K. P., Ramakrishnan, T., and Vaidyanathan, C. S. 
(1966) "Purificatic;:m and Properties of an Inhibitor for 
Nicotinamide-Adenine Dinucleotide from Mycobacterium 
tuberculosis H37Rv." Arch. Biochem. Biophys., 112' 376. 
(171) Suzuki, N. (1968) ·~artial Purificatio~ and Properties of 
Nicotinamide-Adenine Dinucleotide Nucleosidase and Inter-
action Between Enzyme and Its Protein Inhibitor." J. 
Vitamin, !~, 121. 
(172) Olivera, B. M., and Lundquist, R. (1971) "DNA Synthesis in 
Escherichia coli in the Presence of Cyanide." :!.· Mol. 
Biol~, 21, 2~ 
(173) Tritz, G. J., Matney, T. S., Chandler, J. L. R., and Gholson, 
R. K. (1970) "Chromosomal Location of the C Gene Involved 
in the Biosynthesis of Nicotinamide Adenine Dinucleotide in 
Escherichia coli K-12." J. Bacterial., !Q~, 45. 
(174) Chandler, J. L. R., and Gholson, R. K. (1972) "De Novo Bio-
synthesis of Nicotinamide Adenine Dinucleotide in 
Escherichia .££!!.: Excretion of Quinolinic Acid by Mutants 
Lacking Quinolinate Phosphori~osyl Transferase." l_. 
Bacterial.,!!!, 98. 
116 
(175) Tritz, G. J., Matney, t. S., and Gholson, R, K. (1970) "Mapping 
of the natl ~ Locus Adjacent to a Previously Undescribed 
Purine Locus in Escherichia coli K-12." J. Bacterial., !.Q,t, 
377. 
(176) Taylor, A. L. (1970) "Current Linkage Map of Escherichia colL 11 
Bacterial. Rev. , ,2~, 155. 
(177) Chandler, J. L. R., and Gholson, R. K. (1972) 11Studies on the 
de ~ Biosynthesis of NAD in Escherichia coli. II. 
Quantitative Method for Isolating Quinolinic Acid from 
Biological Materials." Anal. Biochem,, ~§, 529. 
(178) Chandler, J. L. R. (1969) Quinolinic Acid Biosynthesis in 
Escherichia coli, Ph.D. Thesis, Oklahoma-state University, 
Department of Biochemistry, Stillwater, Oklahoma. 
(179) Layne, E. (1957) "Spectrophotometric and Turbidimetric Methods 
for Measuring Proteins," in Methods in Enzymology, Vol, III, 
S, P. Colowick and N. O. Kaplan, Ed., Academic Press, Inc., 
N. Y. , p. 44 7 . 
(180) Kerr, T. J,, and Tritz, G. J. (1973) "Cross-Feeding of 
Escherichia coli Mutants Defective in the Biosynthesis of 
Nicotinamide Adenine Dinucleotide." l_. Bacterial., ,!_!_2, 
982. 
(181) Feldberg, R. S., Young, H., Morrice, L.A. F., and Keir, H. M. 
(1972) "Some Observations on the Cofactor Requirement for 
Partially Purified DNA Ligase from Escherichia coli. 11 
Ifill§. Letters, _tz, 345. 
(182) Yates, R. A., and Pardee, A, B. (1956) "Pyrimidine Biosynthesis 
in Escherichia coli. 11 .:!.· BioL Chem, , ~.fl, 7 43. 
(183) Cuatrecasas, P., and Anfinsen, C. B. (1971) "Affinity 
Chromatography," in Methods in Enzymology, Vol. XXII, W. B. 
Jacoby, S. P. Colowick and N. O. Kaplan, Ed,, Academic 
Press, Inc., N. Y., p. 345. 
(184) Cuatrecasas, P., and Parikh, L (1972) "Adsorbents for Affinity 
Chromatography: Use of N-Hydroxysuccinimide Esters of 
Agarose. 11 Biochemistry, !!, 2291. 
(185) Failla, D., and Santi, D. V, (1973) "A Simple Method for 
Quantitating Ligands Covalently Bound to Agarose Beads. 11 
Anal. Biochem., 2.t, 363. 
(186) Wang, C. H., and Willis, D. L, (1965) "Measurement of Radio-
activity by the Liquid (Internal-Sample) Scintillation 
Method," in Radiotracer Methodology in Biological Science, 
Prentice-Hall, Inc., Englewood Cliffs, N. J.,p, 104. 
117 
(187) Weitzman, P, D. J. (1969) ncitrate Synthase from Escherichia 
coli, 11 in Methods in Enzymology, Vol. XIII, J. M. Lowenstein 
Ed., Academic Press, Inc., N. Y., p. 22. 
(188) Davis, B. D., Gilvarg, C., and Mitsuhashi, S. (1955) "Enzymes 
of Aromatic Biosynthesis, 11 in Methods in Enzymology, Vol. 
II, S. P. Colowick and N. 0. Kaplan, Ed., Academic Press, 
Inc., N. Y., P• 300. 
(189) King, T. P. (1972) "Separation of Proteins by Ammonium Sulfate 
Gradient Solubilization. 11 Biochemistry, 11, 367. 
(190) Polson, Ao, Potgieter, G. M., Largier, J, F., Mears, G. E. F., 
and Joubert, F. J. (1964) "The Fractionation of Protein 
Mixtures by Linear Polymers of High Molecular Weight. 11 
Biochim. Biophys. Acta, §~, 463, 
(191) Jones, R. G., and McLaughlin, K. C. (1963) 11 2, 3-Pyrazinedi-
carboxylic Acid," in Org. ~· Collective, Vol. IV, N, 
Rabjohn, Ed., p. 824. 
(192) Rutter, W. J., Hunsley, J. R., Groves, W. E., Calder, J., 
Rajkumar, T. V,, and Woodfin, B. M. (1966) "Fructose 
Diphosphate Aldolase," in Methods in Enzymology, VoL IX, 
W. A. Wood, Ed., Academic Press, N. Y., p. 479. 
I'' 
VITA 
Gary Randel Griffith 
Candidate for the Degree of 
Doctor of Philosophy 
Thesis: PURIFICATION AND SOME PROPERTIES OF THE QUINOLINATE SYNTHETASE 
SYSTEM IN ESCHERICHIA COLI 
Major Field: Biochemistry 
Biographical: 
Personal Data: Born in Oklahoma City, Oklahoma, December 1, 1946, 
the son of Mr. and Mrs. H. R. Griffith. 
Education: Graduated from Guthrie High School in May, 1964; 
received Bachelor of Science degree in Biochemistry from 
Oklahoma State University in 1969; completed requirements for 
the Doctor of Philosophy degree at Oklahoma State University 
in December, 1973. 
Professional Experience: Laboratory technician, Department of 
Biochemistry, Oklahoma State University, September, 1967 to 
May, 1969; Graduate Research Assistant, Department of Bio-
chemistry, Oklahoma State University, June, 1969 to December, 
1973. 
Professional and Honorary Societies: American Scientific Affilia-
tion, Phi Lambda Upsilon. 
